Skip to main content
Redox Biology logoLink to Redox Biology
. 2021 Feb 24;41:101916. doi: 10.1016/j.redox.2021.101916

Interactions of zinc- and redox-signaling pathways

Christopher Hübner 1, Hajo Haase 1,
PMCID: PMC7937829  PMID: 33662875

Abstract

Zinc and cellular oxidants such as reactive oxygen species (ROS) each participate in a multitude of physiological functions. There is considerable overlap between the affected events, including signal transduction. While there is no obvious direct connection between zinc and ROS, mainly because the bivalent cation zinc does not change its oxidation state in biological systems, these are linked by their interaction with sulfur, forming the remarkable triad of zinc, ROS, and protein thiols. First, zinc binds to reduced thiols and can be released upon oxidation. Thereby, redox signals are translated into changes in the free zinc concentration, which can act as zinc signals. Second, zinc affects oxidation of thiols in several ways, directly as well as indirectly. A protein incorporating many of these interactions is metallothionein (MT), which is rich in cysteine and capable of binding up to seven zinc ions in its fully reduced state. Zinc binding is diminished after (partial) oxidation, while thiols show increased reactivity in the absence of bound metal ions. Adding still more complexity, the MT promoter is controlled by zinc (via metal regulatory transcription factor 1 (MTF-1)) as well as redox (via nuclear factor erythroid 2-related factor 2 (NRF2)). Many signaling cascades that are important for cell proliferation or apoptosis contain protein thiols, acting as centers for crosstalk between zinc- and redox-signaling. A prominent example for shared molecular targets for zinc and ROS are active site cysteine thiols in protein tyrosine phosphatases (PTP), their activity being downregulated by oxidation as well as zinc binding. Because zinc binding also protects PTP thiols form irreversible oxidation, there is a multi-faceted reciprocal interaction, illustrating that zinc- and redox-signaling are intricately linked on multiple levels.

Keywords: Zinc, ROS, Redox metabolism, Phosphatases, Caspases, Metallothionein

Graphical abstract

Image 1

Abbreviations

ZIP

Zrt-, Irt-like protein

ZnT

zinc transporter

MT

metallothionein

LPS

lipopolysaccharide

ROS

reactive oxygen species

RS

reactive species

RNS

reactive nitrogen species

NOS

NO synthase

SOD

superoxide dismutase

MAO

Monoamine oxidases

α-KDH

α-ketoglutarate dehydrogenase

NAD+

nicotinamide adenine dinucleotide

XO

xanthine oxidase

XDH

xanthine dehydrogenase

ER

endoplasmic reticulum

GSH

glutathione

GSSG

glutathione disulfide

MMO

microsomal monooxygenase

NADPH

nicotinamide adenine dinucleotide phosphate

Nox

NADPH oxidase

GCS

glutamate cysteine synthetase

Tred

thionein

MTF-1

metal regulatory transcription factor 1

MRE

metal response element

HPLC

high performance liquid chromatography

SDS-PAGE

sodium dodecyl sulfate polyacrylamide gel electrophoresis

PTP

protein tyrosine phosphatase

PSP

protein serine/threonine phosphatase

DUSP

dual-specificity phosphatases

EDTA

ethylenediaminetetraacetic acid

TCEP

tris(2-carboxyethyl)phosphine

PTEN

phosphatase and tensin homolog deleted on chromosome 10

MAKP

MAPK phosphatase

ARE

antioxidant response element

GRE

glucocorticoid response element

Nrf2

nuclear factor erythroid 2-related factor 2

DNA

deoxyribonucleic acid

Keap1

Kelch-like ECH-associated protein 1

NF-κB

nuclear factor κB

MAPK

mitogenactivated protein kinase

AP-1

activator protein 1

PKC

protein kinase C

JNK

Jun N-terminal kinases

ERK

extracellular signal-regulated kinases

MEK

mitogen activated protein kinase kinase

1. Introduction

The trace element zinc is essential for all living organisms. Jules Raulin discovered already in 1869 that zinc is required for the growth of aspergillus niger. [1] Subsequently the biological relevance of zinc was recognized for an increasing number of organisms. E.g., in the 1930's zinc was first described to be essential for rats [2]. Finally, in the 1960's Ananda Prasad and colleagues reported its essentiality for humans [[2], [3], [4]]. On the molecular level, the observation that carbonic anhydrase contains zinc, which is required for enzymatic activity [5], instigated the identification of many further biochemical roles of zinc. In subsequent decades the recognition of zinc in biochemistry increased substantially, as comprehensively reviewed by Maret [6]. Today, many zinc-dependent physiological functions are known. For example, zinc has a crucial role in all phases of wound healing, which is impaired by dysregulated zinc homeostasis [7]. Moreover, the function of the immune system is strongly dependent on zinc. As a second messenger for immune cell signaling, and thus for the functionality of immune cells, zinc is an important regulator of the immune response [[8], [9], [10]].

Many biological processes are redox-dependent [11]. The electron transfer during these redox reactions may lead to the formation of reactive oxygen species (ROS), initializing further redox-processes [12,13]. For maintaining numerous physiological functions a balance between ROS production and ROS elimination is crucial. An overproduction of ROS or lack/inhibition of radical-depleting enzymes leads to dysregulation of this equilibrium and potentially to oxidative stress [14]. The latter is associated with the development of diabetes and cancer, as well as cardiovascular, neurodegenerative, and many other diseases [[15], [16], [17]]. To ensure an appropriate redox homeostasis many different factors are required, one of them being zinc. Zinc itself is redox-inactive and always present in the valence state Zn(II) in biological systems. Thus, zinc cannot directly participate in redox reactions. However, several of its ligands are susceptible to reduction or oxidation, resulting in zinc-binding or oxidative release, respectively. In turn, bound zinc influences the oxidation of its ligands, affecting, e.g., redox modulation of protein function [18,19]. Hence, there is a significant link between zinc and redox metabolism and the functions of zinc in redox metabolism and the crosstalk between zinc signaling and redox signaling will be summarized below.

2. Sources of ROS and important redox couples

Many biological processes under aerobic conditions involve the formation of ROS. These are highly reactive molecules that can function as cell signaling components or may act as toxic metabolites [20]. The term ROS comprises radical molecules (e.g., O2•-, HO) or non-radical molecules, such as H2O2. ROS are produced at different intracellular sites and vary in their properties with regard to reactivity, half-life time and other factors. E.g., the half-life time of HO is over 1000 times lower than for H2O2. Accordingly, in contrast to H2O2, HO swiftly reacts very close to the site of its formation [21]. It has long been known that high concentrations of ROS can react with a range of cellular macromolecules, such as lipids, proteins or nucleic acids, inducing oxidative cell damage. Due to these characteristics they were often exclusively associated with pathophysiological processes. However, nowadays it is known that ROS have many physiological functions, as well, and adequate concentrations are essential, e.g., for signal transduction [[22], [23], [24], [25]]. In most cases, ROS, such as H2O2 or O2•- are generated from molecular oxygen, thus ROS production is dependent on the oxygen concentration [[26], [27], [28]]. The oxygen partial pressure in vivo differs considerably between different tissues (1–100 mm Hg). However, the oxygen concentration mainly ranges between 1 – 10 mm Hg in cells in vivo and only in the lung or some arteries higher concentrations of up to 100 mm Hg occur [29,30]. Hence, the generated ROS concentrations and their potential to influence physiological processes, such as signal transduction, vary between different tissues and cells.

The physiological relevance of cell culture experiments is affected by the availability of oxygen, as well. Most of the experiments that will be discussed in this article were conducted under in vitro cell culture conditions. Typical cell culture conditions (95% air/5% CO2) correspond to an oxygen partial pressure of 150 mm Hg O2 [29], significantly exceeding the abovementioned oxygen partial pressure in vivo of 1 to 100 mm Hg [30]. In case of high O2 concentrations the ROS production is increased [26,27], resulting in significant differences of cellular ROS levels between in vivo and in vitro conditions. In addition, common cell culture media do not contain antioxidants, such as tocopherol or ascorbate, because under these conditions they are insoluble or instable, respectively. Furthermore, selenium, which is necessary for antioxidative systems, such as glutathione peroxidases or for the immune system, is often deficient in cell culture media [31,32]. Hence, in vitro higher amounts of ROS and lower availability antioxidants lead to prooxidative conditions and induction of signaling pathways, which would not be activated in a comparable fashion in vivo [33].

Similar to ROS there exist other reactive species (RS) of physiological relevance. These include reactive nitrogen species (RNS) or reactive sulfur species [34,35]. An example for the “Janus-faced functions” of RNS is nitric monoxide (NO) [36]. The formation of NO from arginine is catalyzed by three isoforms of NO synthase (NOS): neuronal NOS, inducible NOS, and endothelial NOS. A detailed summary of the three isoforms and their different functions is provided by Förstermann et al. [37] On the one hand, NO is important for vasodilation of blood vessels [38]. Furthermore NO modulates signaling cascades, regulating the activity of guanylate cyclase and hereby the formation of the second messenger guanosine 3':5'-cyclic monophosphate [39]. On the other hand, NO can inhibit enzymes, such as catalase [40], or react with O2•-, resulting in the formation of peroxynitrite [41,42]. Comparable to NO, peroxynitrite has beneficial as well as damaging effects. It is a strong oxidant able to kill pathogens [43], but may also lead to cell damage by the oxidation of membrane lipids or the inhibition of the mitochondrial electron transport chain [44,45]. In addition, spontaneous homolytic cleavage of peroxynitrite leads to generation of free radicals such as HO and NO2, which also induce cellular damage [46].

ROS can originate from different intracellular sources (Table 1). Due to their role in respiration, mitochondria contribute significantly to cellular ROS production [47,48]. The respiratory chain contains multiple sites where O2•- is generated through the reduction of oxygen. It is assumed that complex I and complex III are the main sites of O2•- production in the respiratory chain [49,50]. Both complexes release O2•- into the mitochondrial matrix while complex III also releases O2•- into the intermembrane space, because complex III includes two pools of ubiquinone, which are in contact with either matrix or intermembrane space [51]. Under certain conditions succinate dehydrogenase, also known as complex II, contributes significantly to mitochondrial ROS production and is located in the inner mitochondrial membrane, facing toward the mitochondrial matrix, wherein the O2•- is released [52]. O2•- is either converted into H2O2 by superoxide dismutase (SOD), a more stable secondary product or can react with other molecules such as NO within the mitochondrial matrix (Table 2) [50,[53], [54], [55]]. The generated H2O2 mainly moves into the cytosol, however, a part will be decomposed by enzymes such as catalase, peroxiredoxin or glutathione peroxidase in both cellular compartments [56,57]. In addition, H2O2 can participate in the Fenton reaction when free iron ions are present, causing formation of radicals, hereby inducing a prooxidative milieu in mitochondria and other cellular compartments (Table 2) [58]. In addition to the complexes in the respiratory chain, ROS are also generated by various oxidoreductases localized either within one of the mitochondrial membranes or in the mitochondrial matrix. Monoamine oxidases (MAO) as an integral enzyme of the outer membrane catalyze the degradation of biogenic amines with the formation of H2O2 as a side product. Hauptmann et al. have shown that the oxidation of tyramine catalyzed by MAO generates H2O2 [59]. The enzyme α-ketoglutarate dehydrogenase (α-KDH) is localized at the inner membrane. For its function in the citrate acid cycle α-KDH requires nicotinamide adenine dinucleotide (NAD+) as electron acceptor during the oxidative decarboxylation from α-ketoglutarate to succinyl-CoA. A low level of NAD+, and thus a high NADH/NAD+ ratio, can lead to H2O2 production by α-KDH [60]. More examples for oxidoreductases generating ROS in mitochondria were reviewed elsewhere [47,61].

Table 1.

Selected sources of cellular ROS in mammalian metabolism.

Organelle Generated ROS Molecular source References
Mitochondria O2•- Respiratory chain (complex I, II and III) [[49], [50], [51], [52]]
H2O2 Monoamino-oxidase [59]
H2O2 α-ketoglutarate dehydrogenase [60]
O2•- Cytochrome b5 reductase [62]
H2O2 Glycerol 3 phosphate dehydrogenase [63]
H2O2, O2•- Dihydroorotate dehydrogenase [64]
Peroxisomes H2O2 Acyl-CoA oxidases [65]
H2O2, O2•- Xanthine oxidase
H2O2 d-amino acid oxidase
H2O2 Pipecolic acid oxidase
H2O2 d-aspartate oxidase
H2O2 Sarcosine oxidase
H2O2 L-alpha-hydroxy acid oxidase
H2O2 Polyamine oxidase
Cytosol and Plasma membrane H2O2, O2•- Xanthine oxidase [66]
H2O2, O2•- NADPH-oxidase [67,68]
Endoplasmic reticulum (ER) H2O2 Oxidative protein folding [69,70]
O2•- NADH cytochrome b5 reductase [71]
H2O2, O2•- Microsomal monooxygenase [72]
Lysosomes H2O2, O2•- Lysosomal membrane [73,74]

Table 2.

Selected consecutive reactions of ROS.

ROS Consecutive reactions References
O2•- Reaction with NO Formation of ONOO-Conversion into H2O2 [50,53,54]
H2O2 Decomposition by catalase or other enzymes
Fenton reaction Formation of OH
[[55], [56], [57], [58]]
HO Reaction with biomolecules (proteins, lipids)
Induction of DNA damage
[58,75]

Apart from mitochondria, ROS can also be generated by other cellular organelles. Peroxisomes contain many redox-enzymes for performing their physiological tasks, e.g., β-oxidation of fatty acids. Peroxisomal enzymes, in particular oxidases, produce considerable amounts of ROS [76]. The reactions responsible for formation of ROS are similar to the ones in mitochondria, which are described above. Relevant peroxisomal ROS are O2•- and H2O2, whereby the latter may react with metal ions, especially iron, in a Fenton reaction to generate HO (Table 2) [77]. Peroxisomes also contain ROS-scavenging enzymes, such as catalase, peroxidases or dismutases to detoxify ROS [[78], [79], [80]]. In addition, inducible NOS-generated NO may lead to formation of peroxynitrite [81]. Another example for a peroxisomal oxidase is xanthine oxidase (XO) [65]. XO is also present in the cytosol and is one of two forms of xanthine oxidoreductases. The other form is the xanthine dehydrogenase (XDH), which catalyzes the two-step oxidation of hypoxanthine via xanthine to uric acid. During this oxidation NAD+ is used as electron acceptor. In contrast to XDH, XO prefers to use O2 as an electron acceptor, thus generating ROS, such as O2•- or H2O2. Conversion of XDH into its XO form can occur either reversibly, due to disulfide bond formation or irreversibly via proteolysis [82,83] Different ROS-producing oxidases and ROS scavenger enzymes in peroxisomes were summarized by Schrader and Fahimi [65].

The ER has several mechanisms contributing to cellular ROS formation. In contrast to the cytosol, the ER represents a more oxidative environment, mainly due to the lower glutathione (GSH)/glutathione disulfide (GSSG) ratio compared to that of the cytosol (ER: 1:1–3:1; Cytosol:3000:1) [84,85]. This enables oxidative protein folding in the ER, generating intramolecular disulfide bonds to stabilize protein structure. The oxidation of two sulfhydryl groups is catalyzed by protein disulfide isomerase and the ER protein Ero1p, including several disulfide exchange reactions between these proteins. In the process, protein disulfide isomerase is reduced and then oxidized again by Ero1p. In the subsequent oxidation of Erop1 electrons are transferred to O2, whereby H2O2 is formed [69,70]. The desaturation of fatty acids in the ER requires an enzyme system containing NADH cytochrome b5 reductase and cytochrome b5, which act as a transfer component of electrons. This enzyme system represents another source of ROS, because of a potential electron transfer from NADH cytochrome b5 reductase to oxygen [71]. Examples for membrane-associated enzymes and enzyme systems capable of producing ROS are the microsomal monooxygenase (MMO) system or nicotinamide adenine dinucleotide phosphate (NADPH) oxidase (Nox). The MMO system occurs in the membrane of the ER and is involved in the metabolism of xenobiotics. The ability of the MMO system to produce O2•- and H2O2 is known for several decades [72]. The complex reasons for the release of ROS, mainly based on an electron leakage in an electron transport chain, are described in detail elsewhere [86].

Another major cellular source for ROS is the membrane-associated enzyme complex Nox. Nox enzymes are generally inactive and divided into membrane-bound and cytosolic complexes, whereby the latter translocate to the membrane after induction, e.g., by the presence of bacteria, leading to production of bactericidal ROS. O2•- is generated by an electron transport chain transferring electrons from the donor NADPH to molecular oxygen. Seven members of the Nox family are known, which are located in various cells and tissues and are induced in different ways [67,68].

In cellular redox metabolism, several redox equivalents or couples are involved in the exchange of electrons. Redox couples such NAD+/NADH, NADP+/NADPH and 2 GSH/GSSG are essential for the regulation of many cellular processes. Their oxidized to reduced ratios and concentrations reflect the cellular redox state, thus affecting the generation of ROS.

Both, NAD+ and NADP+, are dinucleotides, functioning as redox carriers in countless biochemical pathways. The two molecules can act as cofactors in enzymes or as substrates for redox reactions [87]. Furthermore the two redox couples differ in the respective ratio of oxidized to reduced molecules. In rat livers, the NAD+/NADH and NADP+/NADPH ratios were determined. The mitochondrial membrane is impermeable for NAD+, NADH, NADP+ or NADPH, resulting in separate cellular pools of these molecules and thereby also distinct oxidized/reduced ratios [88]. In the cytoplasm, the range of NAD+/NADH is 700-1,000, whereas in the mitochondria the ratio is 7–8. In contrast, the cytoplasmic NADP+/NADPH ratio is 0.01 [89,90]. Hence, mainly reductive processes are favored by NADPH [91]. Prominent examples for NADPH-dependent enzymes are the members of the Nox family, which are generating ROS due to the reduction of oxygen [67]. A further NAD+ pool is located in the peroxisomes, generated by a peroxisomal membrane-bound transporter for NAD+ and other cofactors [92]. Cellular NAD+ concentrations differ between tissues and the cellular pools have diverse NAD+ contents [91].

GSH is an atypical tripeptide consisting of the amino acids L-γ-glutamic acid, l-cysteine and glycine. GSH serves several cellular functions, most of which involve the thiol at its cysteine sidechain. On the one hand, GSH can be used for phase II metabolization of xenobiotics, where the nucleophilic cysteine group of GSH reacts with molecules activated in phase I. On the other hand, the cysteine group has redox-active properties, serving as a scavenger of ROS, such as H2O2. The reduction of ROS and the resulting oxidation of GSH leads to the formation of the disulfide GSSG, catalyzed by glutathione peroxidase [93]. The enzyme GSSG reductase reduces the accruing GSSG back to GSH using NADPH as electron donor [94,95]. Production of GSH takes place in the cytosol, depending on the availability of cysteine and the activity of the enzyme glutamate cysteine synthetase (GCS). The intracellular concentration of GSH may reach up to 15 mM [96], mainly distributed between cytosol, mitochondria and ER [84,97]. As mentioned above, GSH occurs predominantly in the reduced state [84], thus protecting thiols from irreversible oxidation by oxidants, such as ROS. Additional to the reduction of reversibly oxidized thiol groups, GSH can also prevent irreversible oxidation of thiol groups by reversible oxidative binding to cysteine residues of proteins, called glutathionylation [98]. In the following sections the chemical properties of thiols in metallothionein (MT) and other proteins as well as their role in cellular redox metabolism, particularly regarding the trace element zinc and its homeostasis, is described in more detail.

3. Zinc physiology

The human body contains 2–3 g zinc, making it the second most abundant trace element after iron [99,100]. It is estimated that zinc is a co-factor of 3,000 proteins, including more than 300 enzymes [101]. The largest amount of zinc is found in the muscle (49.5%). In descending order follow bones (36.7%), liver and skin (7.6%), and other tissues (6.2%) [102]. After resorption in the small intestine, the distribution of zinc to the different tissues is mediated via the plasma, where zinc is bound to proteins, mainly to serum albumin and α 2-macroglobulin [103,104]. The homeostasis of zinc is regulated through two classes of zinc transport proteins. On the one hand, the transporter family Zrt-, Irt-like protein (ZIP), which increases the cytosolic zinc concentration, and on the other the “zinc transporter” family (ZnT), which decrease cytosolic zinc concentration through the transport of zinc into cellular compartments or the extracellular space. Fourteen transporters belong to the ZIP family (ZIP 1–14 (SLC39A1-14)) and ten transporters are members of the ZnT family (ZnT 1–10 (SLC30A1-10)) [105], reviewed in detail elsewhere [106,107]. The total cellular zinc concentration is in the range of several hundred micromolar [108]. This intracellular zinc is distributed between cytoplasm (~ 50%), nucleus (~ 30–40%), and the membrane (remainder) [109,110]. The vast majority of cellular zinc ions are bound to proteins, which are either essential for cellular zinc homeostasis, such as MT, or require zinc to maintain their structure or catalytic activity.

Protein-bound zinc has a myriad of important functions. Since the first “zinc-finger” structure was discovered in the 1980's it is known that zinc has a structural role in transcription factors [111,112]. In the following decades the number of known zinc finger proteins increased and it was indicated that zinc finger proteins are a significant part of the transcriptional activators of the human genome [113]. Besides the structural zinc sites in proteins, three other main types of zinc-binding sites exist, catalytic, co-catalytic, and protein interface sites [114,115]. Mainly four amino acids coordinate zinc in proteins; cysteine (cys), aspartic acid (asp), histidine (his) and glutamic acid (glu). Depending on the zinc binding site in the individual protein, zinc is going to be preferably coordinated by different amino acids. Whereas cys-zinc coordination occurs predominantly in structural zinc sites, glu- and asp-zinc coordination may be found in catalytic zinc sites. The amino acid his can coordinate zinc in both zinc binding sites [116].

The fraction of zinc in the cell that is loosely bound to proteins or easily replaceable ligands is called free or labile zinc [117]. The concentration of free zinc varies, depending on cell type and the approach used for its measurement, between picomolar and low nanomolar [118]. Permanent excess or shortage of free zinc are detrimental, because they can lead to inhibition by zinc or loss of protein structure, respectively, and thus to protein dysfunction [118,119]. In case of a temporary increase of the free zinc concentration to 10-8M [118], called “zinc wave” or “zinc flux” (lasting seconds to minutes) or homeostatic zinc signals (persisting for hours), zinc acts as a second messenger [[120], [121], [122]]. Free zinc fluctuations are caused in response of the cell to external stimuli, such as lipopolysaccharide (LPS) or Phorbol-12-myristate-13-acetate [123,124]. Furthermore, the role of zinc as a second messenger in the signal transduction in monocytes and macrophages after stimulation with LPS was shown [124,125]. Three general pathways exist to generate an increase of extracellular or intracellular free zinc concentrations due to a release of zinc ions [126]. Redox signals represent one of these mechanisms for an increase of the cytosolic free zinc concentration. They can lead to oxidation of the zinc binding amino acid side chains, specifically cysteine thiols, resulting in an intracellular oxidative release of zinc ions from proteins [18,[127], [128], [129]]. The other two pathways include the release of zinc ions via vesicular exocytosis and via channels either importing/exporting extracellular zinc or sequestering zinc from intracellular stores, leading to extracellular or intracellular increased free zinc concentrations, respectively [126].

4. Interplay of zinc, thiols and MT

MT was first isolated in 1957 from equine kidney cortex. Back then, the unknown protein stood out because of its low molecular weight and high cadmium content [130]. Further investigations showed high contents not only of cadmium (2.9%), but also zinc (0.6%) and sulfur (4.1%). Due to these findings the protein was named MT [131]. Since its discovery, various functions and properties of MT were identified. Human MT can be divided into four classes (MT-1 to MT-4), comprising eleven functional isoforms eight of which belong to class 1 [132]. MT-1 and MT-2 are ubiquitously distributed in the human body and are expressed in many organs, whereas MT-3 is mainly present in the central nervous system and MT-4 in the skin and other stratified epithelium [133]. All isoforms have a molecular weight of approximately 7 kDa and lack aromatic amino acids [134]. In addition, they have twenty cysteine residues, which confer MT special properties based on the attributes of thiol groups [134,135].

Thiol groups have various biologically relevant features. They occur as nucleophiles in catalytic sites of enzymes or provide structural stability due to formation of disulfide bonds. Due to their redox properties, additional functions of thiol groups are scavenging of radicals, transmission of redox signals or complexation of metal ions, for instance zinc. Generally, the reactivity of the thiol group is important for cysteine functions, which depends, among other things, on its ionization state. A smaller pKA value and thus easier ionization result in higher nucleophilicity, thus affecting their reactivity [136]. The cellular environment determines the ionization state and reactivity of the thiol group [137,138]. For instance, the vicinity of positively charged amino acids or hydrogen bonds facilitates ionization of cysteines and increases the reaction rate [[139], [140], [141]]. Hence pKA values, reactivity, and thus the reaction rate, for instance with oxidants such as H2O2, differ considerably between thiol groups in individual molecules or enzymes [141].

Thiol groups can be oxidized and occur in different oxidation states (-SH, -SS-, -SO-, –SO2-, –SO3-) [135,142]. Oxidation of the thiolate group to sulfenic acid (RSO-) is an intermediate stage that may undergo further oxidations to sulfinic acid (RSO2-) and sulfonic acid (RSO3-) or react with another sulfhydryl/nitrogen group to form a disulfide/sulfenamide. The lower oxidation states (-SS-, -SO-) can be reduced back to sulfhydryl groups, for instance by the GSH/GSSG system [138,143]. In contrast, the reduction of RSO2- and RSO3- represents a challenge [135], whereby the reduction of RSO2- by sulfiredoxins was shown [144,145]. Reversible thiol oxidation represents one of the most important reactions of cysteine residues in vivo. The electron transfer between two thiol modifications or one thiol modification and redox couples like NAD+/NADH is involved in processes such as oxidative protein folding, maintenance of the cellular redox potential or regulation of signaling and gene expression triggered by the exposome [146].

Due to the properties of its vast number of cysteine residues, MT is involved in the homeostasis of essential metals, for instance copper or zinc. Additionally, MT can also bind other metals for detoxification, such as cadmium, or can act as a redox buffer [147]. For both, copper and cadmium, MT has a higher affinity in comparison to zinc [147], but MT seems to be particularly important to maintain cellular zinc homeostasis and plays a critical role in its storage and redistribution [148]. The reduced, metal-free form of the protein, called apo-MT or thionein (Tred), can bind up to seven zinc ions, four of them through complexation by eleven cysteines in the α-domain and three ions bound to nine cysteine residues in the β-domain [149]. In both of these zinc-thiolate clusters each zinc ion is coordinated by four thiolates. Overall the β-domain is more labile in comparison to the α-domain. Accordingly, it can be assumed that the β-domain is preferentially involved in physiological processes, such as scavenging ROS or homeostasis of essential metals, whereas the α-domain seems to be of higher relevance for the detoxification of heavy metals [149]. Accordingly, within one MT molecule, there exist three classes of zinc binding sites, which are distinguishable by their affinities [150]. Four zinc ions are strongly bound with high affinity, two zinc ions with intermediate affinity and one site binds the seventh zinc ion weakly with nanomolar affinity, leading to the hypothesis that a zinc-saturated MT does not occur under normal conditions in vivo [150,151]. Saturation of MT with zinc is possible, e.g., in case of a “zinc flux”, when the intracellular free zinc concentration increases to nanomolar, matching the affinity of the weak zinc binding site [150,152].

Increased intracellular free zinc concentrations induce expression of Tred via the metal regulatory transcription factor 1 (MTF-1), resulting in zinc-sequestration by Tred and thus a downregulation of its availability [153,154]. Next to zinc-buffering, it is suggested that MT is also involved in a specific part of regulation of zinc homeostasis, called zinc-muffling [120]. Zinc muffling includes intracellular processes that change cytosolic zinc concentrations “under non steady state conditions”, whereas zinc-buffering includes processes “under steady state conditions”, as introduced by Colvin et al. [155] Whereas thermodynamic zinc-buffering includes binding and release of zinc in the cytoplasm in order to maintain the free zinc concentration in a picomolar range, zinc-muffling is a kinetic process and contains, for instance, sequestration of zinc either outside the cell or into cellular organelles. The role of MT in zinc-muffling comprises the transfer of zinc to its transporters, which are localized at the plasma membrane or membranes of the respective organelles [120,155]. Hence, Tred and MT are an essential part of intracellular zinc homeostasis, tightly controlling the intracellular free zinc concentration.

In particular during the process of zinc-buffering by MT the redox properties of the thiol groups play a critical role. The cysteine residues in T or MT can be oxidized by cellular oxidants, for example ROS or GSSG, leading to the formation of intramolecular or intermolecular disulfide bonds, resulting in the generation of thionin (Tox) or disulfide-linked MT polymers [19,151,156,157]. In the case of MT the oxidation of the thiol groups results in a release of zinc ions and generates a “zinc flux” [19]. Vice versa, by reducing Tox to Tred, the protein can regain its zinc-binding capability (Fig. 1) [158]. In addition, it was demonstrated that MT is able to transfer zinc to other proteins [159].

Fig. 1.

Fig. 1

MT species occurrence and detection.

The cysteine residues of the apo-protein thionein (Tred) can complex up to seven zinc ions, generating the holo-protein metallothionein (MT). By reactions with cellular oxidants, such as ROS or disulfides, the thiol groups are oxidized to the oxidized form thionin (Tox). Thiol oxidation generates intramolecular or intermolecular disulfide bonds, with concomitant release of zinc, whereas the reduction to Tred induces restoration of zinc-binding. The formation of intermolecular disulfide bonds leads to MT polymers. All three forms of MT can be simultaneously present in the cell. Two assays were developed for analyzing the different MT species by characterizing metal content and oxidation state. One assay is based on sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) after thiol labeling for the investigation of polymer formation due to size separation. Each monomer in combination with the derivation agent has an apparent molecular weight of 14 kDa. Alternatively, the quantification of the different species can be investigated with high performance liquid chromatography (HPLC) after labeling of the free thiol groups with the fluorescent dye 6-iodoacetamidofluoresceine (6-IAF). The amounts of each species can be calculated as the difference between four fluorescence measurements (F). The fluorescence without adding any agents corresponds to the amount of Tred. After addition of a chelating (ethylenediaminetetraacetic acid (EDTA)) or a reducing (tris(2-carboxyethyl)phosphine (TCEP)) agent the fluorescence increases by the amount of metal-bound or oxidized thiol groups, respectively. The difference between the fluorescence after adding chelating or reducing agents and the fluorescence without adding both agents corresponds to the respective amounts of MT or Tox, while measurement in the presence of both TCEP and EDTA gives the sum of all species [19,151,156]..

All three forms of MT co-exist in the cell [156,160]. In general, MT is localized in the cytoplasm and can translocate into the nucleus, to protect DNA from damage and interact with transcription factors [161]. The interaction and scavenging of RS and other oxidants suggests that MT is also a redox buffer [162]. Thiol oxidation by RS releases zinc ions [19], which can induce zinc signals and hereby also the expression of additional Tred to scavenge further RS [153]. The expression of Tred is not only activated by zinc. Aside of other metal ions, such as cadmium, also RS, LPS or other molecules that trigger oxidative stress can upregulate expression of Tred [153]. Among the entirety of MT-inducing metals, xenobiotics and RS, MT expression is most prominently stimulated by cadmium [153,154]. MT expression can be induced by multiple response elements in the MT promoter region: the metal response element (MRE) [154], the antioxidant response element (ARE) [163] and the glucocorticoid response element (GRE) [164]. In the case of zinc, the expression of Tred is activated via the transcription factor MTF-1. MTF-1 is a zinc finger protein and contains six zinc finger domains [165]. After zinc binding, MTF-1 translocates into the nucleus and binds to the MRE promoter region of target genes, hereby upregulating the transcription of Tred and other proteins, such as the zinc transporter ZnT 1 or the enzyme GCS [154,166]. Therefore, MTF-1 is a zinc sensor and induces the expression of various antioxidants and other proteins in a zinc-dependent manner [166]. Cadmium and ROS or other oxidants can also induce expression of Tred [154]. In contrast to zinc, H2O2- or cadmium-mediated Tred expression occurs via a combination of two response elements MRE and ARE [154]. It was shown that the ARE region is responsive to H2O2 and cadmium, but not zinc. In in vitro studies in murine cells, deleting the ARE promoter region of the gene for MT-1 attenuated Tred expression in response to H2O2 and cadmium [154]. In addition, indirect H2O2- or cadmium-mediated Tred expression via MRE is based on zinc release from zinc proteins, resulting in an increase of free zinc and the zinc-dependent activation of MTF-1 [154,167].

The lack of aromatic amino acids in MT represents a challenge for quantitative MT analysis, because standard methods, such as measuring the absorption at 280 nm, are not applicable [134]. Investigation of MT speciation with regard to metal content or oxidation state, is at least equally challenging. Yang et al. developed an assay for simultaneous quantification of the apo-protein Tred and the holo-protein MT [160]. Additionally, an updated method also suited for determining Tox was described (Fig. 1) [156]. This assay is based on labeling of free thiol groups with the fluorescent dye (6-iodoacetamidofluoresceine) 6-IAF. After adding a chelating or a reducing agent, the respective metal-bound or oxidized thiols become accessible for reacting with 6-IAF, allowing a calculation of the relative fractions of the different thiol species by subtracting the signals of free thiols from those obtained in the presence of reducing agents, chelators, or both (Fig. 1). As mentioned above, MT can polymerize through formation of intermolecular disulfide bonds [157]. The polymerization can be analyzed by detecting proteins with molecular weights of multiples of 14 kDa, corresponding to the apparent molecular weight of a monomer in combination with the derivatization agent (Fig. 1) [151].

5. Zinc and redox signaling

The term redox signaling has no uniform definition in the literature [[168], [169], [170], [171]]. For example, Forman et al. characterized redox signaling as involving either a redox reaction or a “covalent adduct formation between the sensor signaling protein and second messenger” [171]. With regard to quantitative measurements of redox signaling, Pillay et al. proposed a working definition for redox signaling: “a kinetic process involving coordinated changes in the oxidation state of redox transduction machinery leading to specific outputs in response to hydrogen peroxide and other oxidants” [169]. Overall, important points for redox signaling processes are the participation of RS and the specificity of the induced reactions and pathways. In contrast to conventional cell signaling pathways, which include second messengers such as cyclic adenosine monophosphate or cyclic guanosine monophosphate, redox signaling involves second messengers with a high potential to undergo unspecific reactions [171]. The wide range of potential reactions of RS comprises, in addition to the reactions that take part in redox signaling, also non-specific oxidations of macromolecules without further signal transduction [169,171]. The reaction of RS with specific targets in redox signaling frequently includes the oxidation/reduction of cysteine residues, which play an essential role in redox metabolism and signaling. The different reactivity and nucleophilicity of the targets, which are determined by their ionization state or their protein environment as already outlined above, provides one part of redox signaling specificity. The other part of this specificity is cellular localization. A short distance between the electrophile and the target protein increases specificity [171]. The major second messengers in redox signaling are peroxides, such as H2O2. Other ROS with higher reactivity, such as O2•- or OH lack specificity [171]. Currently, several mechanisms are known by which H2O2 participates in physiological signaling, such as the regulation of transcription factor activity [172,173].

Zinc has a dual role in redox signaling. On the one hand, it attenuates oxidation of cysteine residues, whose reactivity is diminished upon binding of zinc due to sterical hindrance and its action as a Lewis acid. On the other hand, zinc can be a second messenger in the redox-dependent signaling cascade, subsequent to oxidative release from zinc thiolate complexes, for instance those in MT (Fig. 2) [19].

Fig. 2.

Fig. 2

Redox signaling and its transformation into zinc signals.

Redox signals in the form of RS or other cellular oxidants can oxidize cysteine residues in proteins, resulting in the oxidative release of thiol-bound zinc ions. The proteins that are oxidized can be redox transducers or redox sensors. The redox transducer translates the redox signal into a zinc signal, which can influence the activity of other proteins and can regulate different cellular functions or pathways, such as cell proliferation or expression of antioxidative molecules, respectively. Thus, a redox transducer is oxidized to affect the functions of other proteins. In case of a redox sensors, the aim of the redox signal is the change of the target protein function due to its oxidation, while eventually released zinc is not involved in signaling.

The target proteins of this reversible oxidation, also called redox zinc switches [174], can be divided into redox sensors and redox transducers. Redox sensors are oxidized to change their own function, whereas redox transducers are oxidized to affect other proteins or pathways. A redox sensor can therefore be considered as the recipient of a specific redox signal, whereas the redox transducer is a part of the redox signaling cascade. While zinc that may be released during oxidation of a redox sensor has no specific function, zinc ions that are released from redox transducers actually comprise the next stage in the signaling cascade [175]. Hereby, the redox transducer translates a redox signal into a zinc signal [18,175]. An excellent example for a redox transducer is MT, whereby MT is suggested as “a link between redox and zinc signaling” [175] connecting free zinc and the cellular redox state (Fig. 2) [176].

Increase of free zinc can induce several pathways or transcription factors to regulate antioxidative defense or cellular functions, such as proliferation or apoptosis (Fig. 2). Selected transcription factors or pathways that are influenced by zinc or redox signals are discussed below.

Besides MTF-1, another zinc-sensitive transcription factor is the nuclear factor erythroid 2-related factor 2 (Nrf2). Nrf2 is also a zinc finger protein and translocates into the nucleus after activation [17]. Whereas MTF-1 binds to the MRE promoter region, Nrf2 binds to the ARE promoter region and activates the transcription of multiple antioxidative proteins in response to various kinds of stress [177,178]. Under normal conditions Nrf2 is bound to its repressor protein Kelch-like ECH-associated protein 1 (Keap1), which promotes the degradation of Nrf2. An oxidative modification of cysteine residues from Keap1 leads to conformational changes and the stabilization of Nrf2 [179]. For instance, Nrf2 regulates GCS expression and thus is essential for the regulation of GSH metabolism [180]. Next to oxidants, zinc can also change the conformation of Keap1 and prevent the degradation of Nrf2 [181]. Several in vitro and in vivo studies support the hypothesis of zinc regulating the activity of Nrf2, thus mediating the expression of antioxidative proteins [[182], [183], [184]]. In addition, there are a number of other zinc-modulated transcription factors or zinc proteins (thereby being potential targets for zinc released from redox transducers), such as nuclear factor κB (NF-κB), tristetraprolin, the kruppel-associated box domain proteins or the hepatocyte nuclear factor-4α, which were recently reviewed by Prasad and Bao [17].

Protein phosphatases are a subgroup of phosphatases that dephosphorylate amino acid side chains in proteins. Depending on the specificity for the dephosphorylated amino acid, protein phosphatases can be differentiated into protein tyrosine phosphatases (PTPs), protein serine/threonine phosphatases (PSPs) or dual-specificity phosphatases (DUSPs), which can dephosphorylate all three amino acids [185]. The mechanisms of phosphorylation and dephosphorylation of proteins are essential for cellular signal transduction. Hence kinases and phosphatases are regulating cellular signaling and alterations in their activity are connected to a variety of diseases, such as cancer or autoimmune diseases [186,187].

PTPs can be inhibited by zinc at micromolar, nanomolar, and sometimes even picomolar concentrations [188]. This inhibition is reversible by chelating agents [189], such as ethylenediaminetetraacetic acid (EDTA), or cellular molecules, such as Tred [190]. PTP 1B plays an essential role in insulin signaling by dephosphorylating the insulin receptor [191,192]. Zinc-inhibition of the PTPs 1B and SHP-1 (IC50 values: 17 and 93 nM, respectively) in C6 rat glioma cells resulted in increased phosphorylation of the insulin receptor and the insulin receptor substrate, without affecting activity of the corresponding kinases [193]. Moreover, inhibition of the human T-cell PTP with an IC50 value of 200 nM was observed [190], and the receptor protein-tyrosine phosphatase β was inhibited by picomolar concentrations of zinc [194]. In addition, inhibition of the phosphatase and tensin homolog deleted on chromosome 10 (PTEN) by zinc occurs at approximately 0.6 nM [195]. PTEN is a tumor suppressor and dephosphorylates the second messenger phosphatidylinositol (3,4,5)-trisphosphate, which activates the kinase Akt. Hence, inhibition of PTEN by zinc leads to the activation of cell proliferation and antiapoptotic processes [195]. Physiological zinc concentrations that occur in case of a “zinc flux“ are in the range of the zinc concentrations capable of inhibiting PTPs, suggesting that these are a relevant target of zinc signals [188,196].

Next to inhibition by zinc, two further ways exist to influence the activity of PTPs, which have both been reported for PTP 1B [197,198]. One is a modulation of the activity by phosphorylation [198]. The other, in the context of this review more relevant one, is the reversible oxidation of the cysteine in the catalytic site, e.g., of PTP B1, resulting in its inactivation [197]. The catalytic cysteine of PTP B1 has a low pKa value (~3.8–5.6) and is thus prone for oxidation [199]. PTPs can be inhibited, e.g., through oxidation with H2O2, and reactivated by thiols, such GSH [200]. As another example, the reversible oxidation of PTEN after cell stimulation with growth factors was reported [201]. In fact, insulin and other growth factors induce not only phosphorylation cascades, but also the generation of H2O2, resulting in the oxidative inhibition of phosphatases such as PTP 1B or PTEN [197,201]. In various PTPs the oxidation of the catalytic cysteine initially leads to different oxidation states of sulfur (disulfides, sulfenic acid (RSO-), sulfinic acid (RSO2-) or sulfonic acid (RSO3-)) [202]. Subsequent reactions with neighboring amino acid residues can result in intramolecular crosslinking, due to a sulfenylamide structure or disulfide bonds and thus to structural and conformational changes [203,204]. Notably, it has been shown that zinc binding does not just inhibit PTEN activity, but oxidation of the cysteine residues Cys 124 and Cys 71 of PTEN can be prevented when zinc is bound to the phosphatase. Therefore, temporary reversible inhibition of PTEN, and potentially other PTPs as well, by zinc interferes with their redox-regulation, averting permanent oxidative inhibition [195]. In addition to cysteines, other amino acid residues in phosphatases might be oxidized as well, leading to a loss of enzymatic activity due to alterations in protein folding. Oxidation of the phosphatase PTEN with HOCl results in oxidative modifications such as chlorination or hydroxylation of tyrosine, tryptophan or proline [205]. Yet, to date no effect of zinc on these events has been reported.

Regulation of DUSPs by zinc [206] or oxidation [207] has been shown for mitogen-activated protein kinase phosphatases (MAKPs), which attenuate signaling cascades involved in cell proliferation by dephosphorylation of kinases. The zinc regulation of DUSPs has been shown by a zinc-dependent phosphorylation of the protein kinases mitogen activated protein kinase kinase (MEK) and extracellular signal-regulated kinases (ERK) after interleukin-2 stimulation of T cells, due to inhibition of MAKPs [206]. Furthermore, during oxidative stress in neurons, cysteine thiol oxidation leads to reversible inhibition of ERK-directed phosphatases [207].

For the third group of protein phosphatases, PSPs, Denu and Tanner observed no oxidative inhibition of selected phosphatases by H2O2200, whereas Santos et al. demonstrated inactivation of the PSP protein phosphatase 1 by H2O2 [208]. Addition of reducing thiols did not reactivate protein phosphatase 1, leading to a suggested mechanism involving the oxidation of the dinuclear metal center, in contrast to the catalytic thiol residues that are affected in PTPs [208]. Additionally, the PSPs protein phosphatase 2A and λ Ser/Thr phosphoprotein phosphatase are inhibited by zinc in vitro [209,210].

The results summarized above identify protein phosphatases, in particular PTPs, as an interface between redox and zinc signaling, regulated by a triad of relevant mechanisms. First, they are redox sensors. Second, they are also controlled by zinc signals that can be generated due to oxidation of redox transducers. This makes phosphatases molecules where signals from redox transducer-generated zinc fluxes and redox sensors converge. Third, zinc binding protects cysteine residues in phosphatases from oxidation, making phosphatases a place for crosstalk between zinc- and redox signaling.

In signal transduction, protein phosphatases are the antagonists of protein kinases. Together they regulate the activity of proteins by the transfer of phosphate groups. Hence, protein kinases are, similar to phosphatases, involved in cellular signaling processes regulating apoptosis or cell proliferation. The activity of several kinases is influenced by zinc or redox signals. MAPK, comprising ERK, Jun N-terminal kinases (JNK) and p38 as their main subgroups [211] are involved in signaling pathways regulating cell proliferation and cell death. They are activated through stress stimuli (JNK, p38) or growth factors (ERK). Hence, ROS can induce stress that, in turn, activates the MAPKs JNK and p38 [212]. For example, the apoptotic signal-regulating kinase 1 (ASK1) is involved in p38 and JNK cascades and is responsive to ROS. Its inactive form is bound to reduced thioredoxin, which inhibits the activity of ASK1 [213]. Upon the oxidation of the cysteine residues Cys 32 and Cys 35 in the redox active site of thioredoxin, ASK1 dissociates. Autophosphorylation of a threonine residue (Thr838) by ASK1 then leads to reactivation of its kinase activity, initiating downstream signaling [214]. It seems possible that the critical cysteine residues in thioredoxin bind zinc, which either protects cysteine residues against weaker oxidants or in case of stronger oxidants is released and plays a role as a second messenger. While this has not yet been shown in mammalian signal transduction, it was already observed in E. coli that H2O2 was able to release zinc from thioredoxin 2 [215]. In addition, indirect activation of ERK by ROS was also shown to result from activation of growth factor receptors [216].

Zinc has a differential influence on the individual groups of MAPKs. For example, only p38 is selectively activated in human T-cells by incubation with zinc (in contrast to ERK1/2 or JNK), while after stimulation of the T-cell receptor the phosphorylation of ERK1/2 was inhibited by zinc in a concentration-dependent manner [211]. This can be based on different molecular effects, e.g., zinc-inhibition of specific MAPK-phosphatases can result in higher phosphorylation of ERK1/2 and, alternatively, zinc may also affect receptors upstream of ERK [217], such as PDE/cyclic nucleotide/PKA-mediated inhibitory phosphorylation of Raf-1, which acts upstream of ERK1/2 [218]. The impact of zinc on ERK1/2 activation or phosphorylation state is well documented and modulation of ERK and other MAPK activities has been comprehensively reviewed elsewhere [219,220].

Another important kind of kinases is the protein kinase C (PKC) family, a group of serine/threonine kinases. The catalytic and regulatory domains of PKCs contain cysteine residues that can be oxidized by cellular oxidants. In the regulatory domain C1, two zinc finger domains are present and coordinate zinc ions [221]. In case of an oxidative zinc release due to oxidation of the regulatory domain the activity of PKC increases [222]. In contrast, oxidation of thiol groups in the catalytic domain results in inactivation of PKC [221]. The oxidative inhibition due to oxidation of the catalytic domain requires higher concentrations of oxidants [221]. Hence, conditions of oxidative stress can modulate PKC activity depending on the amount of ROS, affecting several downstream signaling pathways. In addition, Slepchenko et al. showed a regulation of the function of PKC delta by zinc. They suggest a phosphorylation on threonine residue 505 (Thr505) in a free zinc concentration-dependent manner. In case of high intracellular zinc concentrations, a zinc-binding domain blocks the phosphorylation at Thr505 [223].

The caspases, which include 13 members, are cysteine endopeptidases and cleave proteins after aspartic acid sites [224]. Zinc inhibits several caspases. For instance, its half maximal inhibitory concentration for caspase-3, a central effector caspase in apoptosis, was initially found to be <10 nM [190]. In addition, for the caspases 3 (6.9 nM), 6 (2.6 nM), 7 (76.1 nM), and 8 (4.3 nM) nanomolar inhibiting constants were later observed, indicating that they could be relevant targets for zinc in vivo [225]. Caspase 8 binds two zinc ions, one of which is located in the active site of the enzyme (Cys360), while the other zinc binding site remains unknown. Zinc binding to caspase 8 prevents formation of its active form, which is a caspase 8 dimer [225]. Caspases 3 and 7 have three and one zinc binding sites, respectively. In both caspases, one inhibitory zinc binding site is located in the active catalytic dyads of the enzymes [225,226]. In contrast, the inhibitory zinc binding site of caspase 6 is allosteric, involving the amino acids Lys-36, Glu-244 and His-287 [227]. Zinc inhibition of caspase 9 was reported in the micromolar range [228,229]. Huber et al. investigated two binding sites in caspase 9 for zinc inhibition. One site involves the catalytic site of caspase 9, in particular the catalytic histidine (His 237) and cysteine (Cys 287) residues, whereas the other site comprises a cysteine residue (Cys 272) that is located away from the catalytic site [229]. Aside of their inhibition by zinc, caspases can also be regulated by oxidative modifications, such as glutathionylation [230], nitrosylation [231] or persulfidation [232]. Caspase 3 was shown to be inhibited by micromolar concentrations of GSSG (IC50: 75 μM), due to glutathionylation of the cysteine residues Cys 45 on p12 subunit and Cys 135 on p17 subunit (active site), whereby the inhibition is reversible by the addition of reducing agents, such as GSH [230]. Consequently, caspase 3 can already be oxidatively inhibited by physiological GSSG concentrations (up to 120 μM) [233]. Nitrosylation was reported to inhibit the active cysteine residue of caspase 3 as well as to decline the cleavage of procaspase 9 into its active form and consequently decreases apoptosis [231,234].

It seems worthwhile to look for parallels in the regulation of caspases and PTPs. Both enzyme families have an active site cysteine, and several members of the respective families have been shown to be a target for regulation by zinc as well as redox. While this has not yet been substantiated by experimental evidence, the active site cysteine in caspases might be a target for multiple forms of crosstalk between zinc and redox signaling similar to the one in PTPs, including a protective effect of zinc from oxidative inactivation.

6. Alterations in zinc status and their influence on redox homeostasis and signaling

Zinc deficiency can occur due to several reasons, including malnutrition or other dietary causes, such as the intake of high amounts of zinc-chelating factors, most prominently phytate [235]. This nutritional deficiency is linked to increased apoptosis, chronic inflammation and oxidative stress, potentially contributing to chronic diseases [17,236,237]. Especially elderly people are prone to zinc deficiency, resulting in impaired efficiency of the immune system and other systematic dysfunctions [238,239]. These adverse effects of zinc deficiency in the elderly can be reversed by zinc supplementation [240]. Zinc excess due to disproportionate zinc supplementation can also lead to oxidative stress [18,241]. In general, high zinc levels can interrupt important processes, such as citrate acid cycle or glycolysis, due to a reduction in NADH production [242] or enzyme inhibition of phosphofructokinase [243]. Furthermore, zinc activation of lipoamide dehydrogenase, which is a part of the α-KDH complex and catalyzes the production of H2O2, leads to an increase of ROS production [244]. Overall, zinc has predominantly antioxidative functions, whereas alterations in zinc status lead to prooxidative conditions [18].

Furthermore, on the cellular level zinc deficiency or excess influence redox homeostasis and redox signaling. Alterations in zinc status can lead to an overproduction of RS and thus to oxidative stress. Accordingly, the activity of antioxidative enzymes, such as copper/zinc SOD is increased during zinc deprivation, acting as a protective mechanism against oxidative damage [245]. Vice versa, copper/zinc SOD activity is reduced during zinc excess, because copper is essential for the activity of copper/zinc SOD and elevated zinc levels can lead to copper deficiency [18,246]. Normal zinc levels are essential for expression of antioxidative molecules, resulting in a significant shift of the pro-oxidative/anti-oxidative balance to the side of pro-oxidative conditions during zinc deficiency. These oxidative conditions affect various cellular pathways or transcription factors, which are involved in mechanisms such as cell proliferation or apoptosis [245]. For instance, zinc deficiency reduced the tyrosine phosphorylation of the transcription factors signal transducer and activator of transcription (STAT) 1 and STAT 3, whereas serine phosphorylation is increased, due to the activation of the MAPK p38 by oxidative stress [247]. In addition, oxidative conditions during zinc deficiency impair the translocation of STAT 1 and STAT 3 into the nucleus. Furthermore the MAPKs p38 and JNK activity is increased during zinc deficiency, whereas ERK 1/2 activity is decreased. [247,248] In addition, the binding activities of other transcription factors, such the activator protein 1 (AP-1) or NF-κB, are increased or decreased, respectively, by zinc deficiency. This is in accordance with the theory of higher ROS levels or lower amounts of antioxidants during zinc deficiency, as dysregulation of redox equilibrium modulates these transcription factors [245,248,249].

An example for the disrupted generation of antioxidative molecules during zinc deficiency is the reduced formation of GSH in in vitro studies, due to inhibited expression of the glutamate cysteine ligase subunits, but also through the activation of Caspase 3, which cleaves the GCS, an essential enzyme for GSH generation [250].

7. Conclusion

Zinc plays an essential role in redox metabolism and signaling. Alterations in cellular zinc homeostasis are crucial for the prooxidative/antioxidative equilibrium and can lead to a shift to prooxidative conditions, resulting in life threatening diseases. Zinc and redox signals are connected by the oxidative release of zinc from proteins, for example MT, due to oxidation of thiol groups, switching a redox signal into a zinc signal. This increased free zinc concentration, called “zinc flux”, affects proteins such as phosphatases or caspases and pathways regulating cell proliferation, apoptosis or expression of proteins, e.g. Tred. In addition, zinc can protect proteins from oxidation thereby preserving their functions.

However, Maret suggested that these investigations need to be carefully reinterpreted to distinguish physiological zinc signaling from pathophysiological influences on protein functions, considering the physiologically occurring free zinc concentrations [18]. Another point that needs to be questioned is the representativeness of in vitro cell culture tests for investigations regarding redox metabolism and signaling. The higher amounts of ROS in cell culture experiments may lead to results that do not adequately represent redox-related processes in vivo.

Taken together many parallel targets and interactions for zinc and redox metabolism have been described. Yet, the physiological relevance of existing observations as well as a myriad of unidentified molecular sites of their mutual interaction remain to be elucidated.

Acknowledgment

This work was supported by the Deutsche Forschungsgemeinschaft (DFG – German Research Foundation), grant number HA 4318/6-1.

References

  • 1.Raulin J. Etudes chimiques sur la vegetation. Annales des sciences naturelles. 1869;11:92–299. [Google Scholar]
  • 2.Todd W.R., Elvehjem C.A., Hart E.B. Zinc in the nutrition of the rat. Nutr. Rev. 1980;38:151–154. doi: 10.1111/j.1753-4887.1980.tb05879.x. [DOI] [PubMed] [Google Scholar]
  • 3.Prasad A.S., Halsted J.A., Nadimi M. Syndrome of iron deficiency anemia, hepatosplenomegaly, hypogonadism, dwarfism and geophagia. Am. J. Med. 1961;31:532–546. doi: 10.1016/0002-9343(61)90137-1. [DOI] [PubMed] [Google Scholar]
  • 4.Prasad A.S., Miale A., Jr., Farid Z., Sandstead H.H., Schulert A.R. Zinc metabolism in patients with the syndrome of iron deficiency anemia, hepatosplenomegaly, dwarfism, and hypognadism. J. Lab. Clin. Med. 1963;61:537–549. [PubMed] [Google Scholar]
  • 5.Keilin D., Mann T. Carbonic Anhydrase. Nature. 1939;144:442–443. doi: 10.1038/144442b0. [DOI] [Google Scholar]
  • 6.Maret W. Zinc biochemistry: from a single zinc enzyme to a key element of life. Advances in Nutrition. 2013;4:82–91. doi: 10.3945/an.112.003038. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Lin P.H. Zinc in wound healing modulation. Nutrients. 2017;10 doi: 10.3390/nu10010016. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Haase H., Rink L. Multiple impacts of zinc on immune function. Metall. 2014;6:1175–1180. doi: 10.1039/c3mt00353a. [DOI] [PubMed] [Google Scholar]
  • 9.Haase H., Rink L. Zinc signals and immune function. Biofactors. 2014;40:27–40. doi: 10.1002/biof.1114. [DOI] [PubMed] [Google Scholar]
  • 10.Maares M., Haase H. Zinc and immunity: an essential interrelation. Arch. Biochem. Biophys. 2016;611:58–65. doi: 10.1016/j.abb.2016.03.022. [DOI] [PubMed] [Google Scholar]
  • 11.Hosios A.M., Vander Heiden M.G. The redox requirements of proliferating mammalian cells. J. Biol. Chem. 2018;293:7490–7498. doi: 10.1074/jbc.tm117.000239. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Grek C.L., Tew K.D. Redox metabolism and malignancy. Curr. Opin. Pharmacol. 2010;10:362–368. doi: 10.1016/j.coph.2010.05.003. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Michael Unraveling the biological roles of reactive oxygen species. Cell Metabol. 2011;13:361–366. doi: 10.1016/j.cmet.2011.03.010. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Sies H. Oxidative stress: from basic research to clinical application. Am. J. Med. 1991;91:S31–S38. doi: 10.1016/0002-9343(91)90281-2. [DOI] [PubMed] [Google Scholar]
  • 15.Valko M. Free radicals and antioxidants in normal physiological functions and human disease. Int. J. Biochem. Cell Biol. 2007;39:44–84. doi: 10.1016/j.biocel.2006.07.001. [DOI] [PubMed] [Google Scholar]
  • 16.Hecht F. The role of oxidative stress on breast cancer development and therapy. Tumor Biol. 2016;37:4281–4291. doi: 10.1007/s13277-016-4873-9. [DOI] [PubMed] [Google Scholar]
  • 17.Prasad A.S., Bao B. Molecular mechanisms of zinc as a pro-antioxidant mediator: clinical therapeutic implications. Antioxidants (Basel) 2019;8 doi: 10.3390/antiox8060164. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Maret W. The redox biology of redox-inert zinc ions. Free Radic. Biol. Med. 2019;134:311–326. doi: 10.1016/j.freeradbiomed.2019.01.006. [DOI] [PubMed] [Google Scholar]
  • 19.Maret W., Vallee B.L. Thiolate ligands in metallothionein confer redox activity on zinc clusters. Proc. Natl. Acad. Sci. Unit. States Am. 1998;95:3478–3482. doi: 10.1073/pnas.95.7.3478. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Brieger K., Schiavone S., Miller F.J., Jr., Krause K.H. Reactive oxygen species: from health to disease. Swiss Med. Wkly. 2012;142:w13659. doi: 10.4414/smw.2012.13659. [DOI] [PubMed] [Google Scholar]
  • 21.Mittler R. ROS are good. Trends Plant Sci. 2017;22:11–19. doi: 10.1016/j.tplants.2016.08.002. [DOI] [PubMed] [Google Scholar]
  • 22.Finkel T. Signal transduction by reactive oxygen species. J. Cell Biol. 2011;194:7–15. doi: 10.1083/jcb.201102095. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Schieber M., Chandel Navdeep S. ROS function in redox signaling and oxidative stress. Curr. Biol. 2014;24:R453–R462. doi: 10.1016/j.cub.2014.03.034. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Mittal C.K., Murad F. Activation of guanylate cyclase by superoxide dismutase and hydroxyl radical: a physiological regulator of guanosine 3',5'-monophosphate formation. Proc. Natl. Acad. Sci. Unit. States Am. 1977;74:4360–4364. doi: 10.1073/pnas.74.10.4360. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Hamanaka R.B., Chandel N.S. Mitochondrial reactive oxygen species regulate cellular signaling and dictate biological outcomes. Trends Biochem. Sci. 2010;35:505–513. doi: 10.1016/j.tibs.2010.04.002. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Yusa T., Crapo J., Freeman B. Hyperoxia enhances lung and liver nuclear superoxide generation. Biochim. Biophys. Acta. 1984;798:167–174. doi: 10.1016/0304-4165(84)90299-x. [DOI] [PubMed] [Google Scholar]
  • 27.Turrens J.F., Freeman B.A., Levitt J.G., Crapo J.D. The effect of hyperoxia on superoxide production by lung submitochondrial particles. Arch. Biochem. Biophys. 1982;217:401–410. doi: 10.1016/0003-9861(82)90518-5. [DOI] [PubMed] [Google Scholar]
  • 28.Stepanova A. The dependence of brain mitochondria reactive oxygen species production on oxygen level is linear, except when inhibited by antimycin A. J. Neurochem. 2019;148:731–745. doi: 10.1111/jnc.14654. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Halliwell B. Oxidative stress in cell culture: an under-appreciated problem? FEBS Letters. 2003;540:3–6. doi: 10.1016/s0014-5793(03)00235-7. [DOI] [PubMed] [Google Scholar]
  • 30.De Groot H., Littauer A. Hypoxia, reactive oxygen, and cell injury. Free Radic. Biol. Med. 1989;6:541–551. doi: 10.1016/0891-5849(89)90047-6. [DOI] [PubMed] [Google Scholar]
  • 31.Baker R.D., Jr., Baker S.S., Rao R. Selenium deficiency in tissue culture: implications for oxidative metabolism. J. Pediatr. Gastroenterol. Nutr. 1998;27:387–392. doi: 10.1097/00005176-199810000-00003. [DOI] [PubMed] [Google Scholar]
  • 32.Haase H., Schomburg L. You'd better zinc-trace element homeostasis in infection and inflammation. Nutrients. 2019;11:2078. doi: 10.3390/nu11092078. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Halliwell B. Biochemistry of oxidative stress. Biochem. Soc. Trans. 2007;35:1147–1150. doi: 10.1042/bst0351147. [DOI] [PubMed] [Google Scholar]
  • 34.Lushchak V.I. Free radicals, reactive oxygen species, oxidative stress and its classification. Chem. Biol. Interact. 2014;224:164–175. doi: 10.1016/j.cbi.2014.10.016. [DOI] [PubMed] [Google Scholar]
  • 35.Di Meo S., Reed T.T., Venditti P., Victor V.M. Role of ROS and RNS sources in physiological and pathological conditions. Oxidative.Med. Cell.Longevity. 2016;2016:1–44. doi: 10.1155/2016/1245049. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.Calabrese V. Nitric oxide in cell survival: a janus molecule. Antioxidants Redox Signal. 2009;11:2717–2739. doi: 10.1089/ars.2009.2721. [DOI] [PubMed] [Google Scholar]
  • 37.Forstermann U., Sessa W.C. Nitric oxide synthases: regulation and function. Eur. Heart J. 2012;33:829–837. doi: 10.1093/eurheartj/ehr304. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38.Ignarro L.J., Buga G.M., Wood K.S., Byrns R.E., Chaudhuri G. Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide. Proc. Natl. Acad. Sci. Unit. States Am. 1987;84:9265–9269. doi: 10.1073/pnas.84.24.9265. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39.Arnold W.P., Mittal C.K., Katsuki S., Murad F. Nitric oxide activates guanylate cyclase and increases guanosine 3':5'-cyclic monophosphate levels in various tissue preparations. Proc. Natl. Acad. Sci. Unit. States Am. 1977;74:3203–3207. doi: 10.1073/pnas.74.8.3203. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40.Brunelli L., Yermilov V., Beckman J.S. Modulation of catalase peroxidatic and catalatic activity by nitric oxide. Free Radic. Biol. Med. 2001;30:709–714. doi: 10.1016/s0891-5849(00)00512-8. [DOI] [PubMed] [Google Scholar]
  • 41.Huie R.E., Padmaja S. The reaction of no with superoxide. Free Radic. Res. Commun. 1993;18:195–199. doi: 10.3109/10715769309145868. [DOI] [PubMed] [Google Scholar]
  • 42.Blough N.V., Zafiriou O.C. Reaction of superoxide with nitric oxide to form peroxonitrite in alkaline aqueous solution. Inorg. Chem. 1985;24:3502–3504. doi: 10.1021/ic00216a003. [DOI] [Google Scholar]
  • 43.Prolo C., Álvarez M.N., Radi R. Peroxynitrite, a potent macrophage-derived oxidizing cytotoxin to combat invading pathogens. Biofactors. 2014;40:215–225. doi: 10.1002/biof.1150. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 44.Radi R., Beckman J.S., Bush K.M., Freeman B.A. Peroxynitrite-induced membrane lipid peroxidation: the cytotoxic potential of superoxide and nitric oxide. Arch. Biochem. Biophys. 1991;288:481–487. doi: 10.1016/0003-9861(91)90224-7. [DOI] [PubMed] [Google Scholar]
  • 45.Radi R., Rodriguez M., Castro L., Telleri R. Inhibition of mitochondrial electron transport by peroxynitrite. Arch. Biochem. Biophys. 1994;308:89–95. doi: 10.1006/abbi.1994.1013. [DOI] [PubMed] [Google Scholar]
  • 46.Radi R. Peroxynitrite, a stealthy biological oxidant. J. Biol. Chem. 2013;288:26464–26472. doi: 10.1074/jbc.r113.472936. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 47.Wong H.S., Dighe P.A., Mezera V., Monternier P.A., Brand M.D. Production of superoxide and hydrogen peroxide from specific mitochondrial sites under different bioenergetic conditions. J. Biol. Chem. 2017;292:16804–16809. doi: 10.1074/jbc.R117.789271. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 48.Brand M.D. Mitochondrial generation of superoxide and hydrogen peroxide as the source of mitochondrial redox signaling. Free Radic. Biol. Med. 2016;100:14–31. doi: 10.1016/j.freeradbiomed.2016.04.001. [DOI] [PubMed] [Google Scholar]
  • 49.Turrens J.F., Boveris A. Generation of superoxide anion by the NADH dehydrogenase of bovine heart mitochondria. Biochem. J. 1980;191:421–427. doi: 10.1042/bj1910421. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 50.Cadenas E., Boveris A., Ragan C.I., Stoppani A.O.M. Production of superoxide radicals and hydrogen peroxide by NADH-ubiquinone reductase and ubiquinol-cytochrome c reductase from beef-heart mitochondria. Arch. Biochem. Biophys. 1977;180:248–257. doi: 10.1016/0003-9861(77)90035-2. [DOI] [PubMed] [Google Scholar]
  • 51.Han D., Williams E., Cadenas E. Mitochondrial respiratory chain-dependent generation of superoxide anion and its release into the intermembrane space. Biochem. J. 2001;353:411. doi: 10.1042/0264-6021:3530411. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 52.McLennan H.R., Degli Esposti M. The contribution of mitochondrial respiratory complexes to the production of reactive oxygen species. J. Bioenerg. Biomembr. 2000;32:153–162. doi: 10.1023/a:1005507913372. [DOI] [PubMed] [Google Scholar]
  • 53.Loschen G., Azzi A., Richter C., Flohé L. Superoxide radicals as precursors of mitochondrial hydrogen peroxide. FEBS Letters. 1974;42:68–72. doi: 10.1016/0014-5793(74)80281-4. [DOI] [PubMed] [Google Scholar]
  • 54.Packer M.A., Porteous C.M., Murphy M.P. Superoxide production by mitochondria in the presence of nitric oxide forms peroxynitrite. Biochem. Mol. Biol. Int. 1996;40:527–534. doi: 10.1080/15216549600201103. [DOI] [PubMed] [Google Scholar]
  • 55.Weisiger R.A., Fridovich I. Superoxide dismutase: organelle specificity. J. Biol. Chem. 1973;248:3582–3592. [PubMed] [Google Scholar]
  • 56.Salvi M. Catalase takes part in rat liver mitochondria oxidative stress defense. J. Biol. Chem. 2007;282:24407–24415. doi: 10.1074/jbc.m701589200. [DOI] [PubMed] [Google Scholar]
  • 57.Rhee S.G., Yang K.-S., Kang S.W., Woo H.A., Chang T.-S. Controlled elimination of intracellular H 2 O2 : regulation of peroxiredoxin, catalase, and glutathione peroxidase via post-translational modification. Antioxidants Redox Signal. 2005;7:619–626. doi: 10.1089/ars.2005.7.619. [DOI] [PubMed] [Google Scholar]
  • 58.Karbownik-Lewińska M., Stępniak J., Lewiński A. High level of oxidized nucleosides in thyroid mitochondrial DNA; damaging effects of Fenton reaction substrates. Thyroid Res. 2012;5:24. doi: 10.1186/1756-6614-5-24. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 59.Hauptmann N., Grimsby J., Shih J.C., Cadenas E. The metabolism of tyramine by monoamine oxidase A/B causes oxidative damage to mitochondrial DNA. Arch. Biochem. Biophys. 1996;335:295–304. doi: 10.1006/abbi.1996.0510. [DOI] [PubMed] [Google Scholar]
  • 60.Tretter L. Generation of reactive oxygen species in the reaction catalyzed by α-ketoglutarate dehydrogenase. J. Neurosci. 2004;24:7771–7778. doi: 10.1523/jneurosci.1842-04.2004. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 61.Andreyev A.Y., Kushnareva Y.E., Starkov A.A. Mitochondrial metabolism of reactive oxygen species. Biochemistry (Mosc.) 2005;70:200–214. doi: 10.1007/s10541-005-0102-7. [DOI] [PubMed] [Google Scholar]
  • 62.Whatley S.A. Superoxide, neuroleptics and the ubiquinone and cytochrome b5 reductases in brain and lymphocytes from normals and schizophrenic patients. Mol. Psychiatr. 1998;3:227–237. doi: 10.1038/sj.mp.4000375. [DOI] [PubMed] [Google Scholar]
  • 63.Tretter L., Takacs K., Hegedus V., Adam-Vizi V. Characteristics of alpha-glycerophosphate-evoked H2O2 generation in brain mitochondria. J. Neurochem. 2007;100:650–663. doi: 10.1111/j.1471-4159.2006.04223.x. [DOI] [PubMed] [Google Scholar]
  • 64.Hey-Mogensen M., Goncalves R.L.S., Orr A.L., Brand M.D. Production of superoxide/H2O2 by dihydroorotate dehydrogenase in rat skeletal muscle mitochondria. Free Radic. Biol. Med. 2014;72:149–155. doi: 10.1016/j.freeradbiomed.2014.04.007. [DOI] [PubMed] [Google Scholar]
  • 65.Schrader M., Fahimi H.D. Peroxisomes and oxidative stress. Biochim. Biophys. Acta Mol. Cell Res. 2006;1763:1755–1766. doi: 10.1016/j.bbamcr.2006.09.006. [DOI] [PubMed] [Google Scholar]
  • 66.Schmidt H.M., Kelley E.E., Straub A.C. The impact of xanthine oxidase (XO) on hemolytic diseases. Redox Biology. 2019;21:101072. doi: 10.1016/j.redox.2018.101072. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 67.Katsuyama M. NOX/NADPH oxidase, the superoxide-generating enzyme: its transcriptional regulation and physiological roles. J. Pharmacol. Sci. 2010;114:134–146. doi: 10.1254/jphs.10r01cr. [DOI] [PubMed] [Google Scholar]
  • 68.Bedard K., Krause K.-H. The NOX family of ROS-generating NADPH oxidases: physiology and pathophysiology. Physiol. Rev. 2007;87:245–313. doi: 10.1152/physrev.00044.2005. [DOI] [PubMed] [Google Scholar]
  • 69.Tu B.P., Weissman J.S. The FAD- and O2-dependent reaction cycle of Ero1-mediated oxidative protein folding in the endoplasmic reticulum. Mol. Cell. 2002;10:983–994. doi: 10.1016/S1097-2765(02)00696-2. [DOI] [PubMed] [Google Scholar]
  • 70.Gross E. Generating disulfides enzymatically: reaction products and electron acceptors of the endoplasmic reticulum thiol oxidase Ero1p. Proc. Natl. Acad. Sci. Unit. States Am. 2006;103:299–304. doi: 10.1073/pnas.0506448103. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 71.Samhan-Arias A., Gutiérrez-Merino C. Purified NADH-cytochrome b5 reductase is a novel superoxide anion source inhibited by apocynin: sensitivity to nitric oxide and peroxynitrite. Free Radic. Biol. Med. 2014;73 doi: 10.1016/j.freeradbiomed.2014.04.033. [DOI] [PubMed] [Google Scholar]
  • 72.Kuthan H., Ullrich V. Oxidase and oxygenase function of the microsomal cytochrome P450 monooxygenase system. Eur. J. Biochem. 1982;126:583–588. doi: 10.1111/j.1432-1033.1982.tb06820.x. [DOI] [PubMed] [Google Scholar]
  • 73.Gille L., Nohl H. The existence of a lysosomal redox chain and the role of ubiquinone. Arch. Biochem. Biophys. 2000;375:347–354. doi: 10.1006/abbi.1999.1649. [DOI] [PubMed] [Google Scholar]
  • 74.Nohl H., Gille L. The bifunctional activity of ubiquinone in lysosomal membranes. Biogerontology. 2002;3:125–131. doi: 10.1023/a:1015288220217. [DOI] [PubMed] [Google Scholar]
  • 75.Lipinski B. Hydroxyl radical and its scavengers in health and disease. Oxidative.Med. Cell.Longevity. 2011;2011:1–9. doi: 10.1155/2011/809696. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 76.Boveris A., Oshino N., Chance B. The cellular production of hydrogen peroxide. Biochem. J. 1972;128:617–630. doi: 10.1042/bj1280617. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 77.Dansen B., Wirtz K.W. The peroxisome in oxidative stress. IUBMB Life. 2001;51:223–230. doi: 10.1080/152165401753311762. [DOI] [PubMed] [Google Scholar]
  • 78.Keller G.A., Warner T.G., Steimer K.S., Hallewell R.A. Cu,Zn superoxide dismutase is a peroxisomal enzyme in human fibroblasts and hepatoma cells. Proc. Natl. Acad. Sci. U.S.A. 1991;88:7381–7385. doi: 10.1073/pnas.88.16.7381. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 79.Singh A.K. Demonstration of glutathione peroxidase in rat liver peroxisomes and its intraorganellar distribution. Arch. Biochem. Biophys. 1994;315:331–338. doi: 10.1006/abbi.1994.1508. [DOI] [PubMed] [Google Scholar]
  • 80.Siraki A.G., Pourahmad J., Chan T.S., Khan S., O’Brien P.J. Endogenous and endobiotic induced reactive oxygen species formation by isolated hepatocytes. Free Radic. Biol. Med. 2002;32:2–10. doi: 10.1016/S0891-5849(01)00764-X. [DOI] [PubMed] [Google Scholar]
  • 81.Stolz D. Peroxisomal localization of inducible nitric oxide synthase in hepatocytes. Hepatology. 2002;36:81–93. doi: 10.1053/jhep.2002.33716. [DOI] [PubMed] [Google Scholar]
  • 82.Cantu-Medellin N., Kelley E.E. Xanthine oxidoreductase-catalyzed reactive species generation: a process in critical need of reevaluation. Redox Biology. 2013;1:353–358. doi: 10.1016/j.redox.2013.05.002. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 83.Nishino T., Okamoto K., Eger B.T., Pai E.F., Nishino T. Mammalian xanthine oxidoreductase - mechanism of transition from xanthine dehydrogenase to xanthine oxidase. FEBS J. 2008;275:3278–3289. doi: 10.1111/j.1742-4658.2008.06489.x. [DOI] [PubMed] [Google Scholar]
  • 84.Hwang C., Sinskey A., Lodish H. Oxidized redox state of glutathione in the endoplasmic reticulum. Science. 1992;257:1496–1502. doi: 10.1126/science.1523409. [DOI] [PubMed] [Google Scholar]
  • 85.Hu J., Dong L., Outten C.E. The redox environment in the mitochondrial intermembrane space is maintained separately from the cytosol and matrix. J. Biol. Chem. 2008;283:29126–29134. doi: 10.1074/jbc.M803028200. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 86.Davydov D.R. Microsomal monooxygenase in apoptosis: another target for cytochrome c signaling? Trends Biochem. Sci. 2001;26:155–160. doi: 10.1016/s0968-0004(00)01749-7. [DOI] [PubMed] [Google Scholar]
  • 87.Xiao W., Wang R.S., Handy D.E., Loscalzo J. NAD(H) and NADP(H) redox couples and cellular energy metabolism. Antioxidants Redox Signal. 2018;28:251–272. doi: 10.1089/ars.2017.7216. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 88.Yang H. Nutrient-sensitive mitochondrial NAD+ levels dictate cell survival. Cell. 2007;130:1095–1107. doi: 10.1016/j.cell.2007.07.035. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 89.Stubbs M., Veech R.L., Krebs H.A. Control of the redox state of the nicotinamide-adenine dinucleotide couple in rat liver cytoplasm. Biochem. J. 1972;126:59–65. doi: 10.1042/bj1260059. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 90.Veech R.L., Eggleston L.V., Krebs H.A. The redox state of free nicotinamide-adenine dinucleotide phosphate in the cytoplasm of rat liver. Biochem. J. 1969;115:609–619. doi: 10.1042/bj1150609a. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 91.Houtkooper R.H., Canto C., Wanders R.J., Auwerx J. The secret life of NAD+: an old metabolite controlling new metabolic signaling pathways. Endocr. Rev. 2010;31:194–223. doi: 10.1210/er.2009-0026. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 92.Agrimi G., Russo A., Scarcia P., Palmieri F. The human gene SLC25A17 encodes a peroxisomal transporter of coenzyme A, FAD and NAD+ Biochem. J. 2012;443:241–247. doi: 10.1042/bj20111420. [DOI] [PubMed] [Google Scholar]
  • 93.Flohe L., Günzler W.A., Schock H.H. Glutathione peroxidase: a selenoenzyme. FEBS Letters. 1973;32:132–134. doi: 10.1016/0014-5793(73)80755-0. [DOI] [PubMed] [Google Scholar]
  • 94.Lu S.C. Regulation of glutathione synthesis. Mol. Aspect. Med. 2009;30:42–59. doi: 10.1016/j.mam.2008.05.005. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 95.Schulz G.E., Schirmer R.H., Sachsenheimer W., Pai E.F. The structure of the flavoenzyme glutathione reductase. Nature. 1978;273:120–124. doi: 10.1038/273120a0. [DOI] [PubMed] [Google Scholar]
  • 96.Deponte M. Glutathione catalysis and the reaction mechanisms of glutathione-dependent enzymes. Biochim. Biophys. Acta Gen. Subj. 2013;1830:3217–3266. doi: 10.1016/j.bbagen.2012.09.018. [DOI] [PubMed] [Google Scholar]
  • 97.Griffith O.W., Meister A. Origin and turnover of mitochondrial glutathione. Proc. Natl. Acad. Sci. U.S.A. 1985;82:4668–4672. doi: 10.1073/pnas.82.14.4668. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 98.Dalle-Donne I., Rossi R., Giustarini D., Colombo R., Milzani A. S-glutathionylation in protein redox regulation. Free Radic. Biol. Med. 2007;43:883–898. doi: 10.1016/j.freeradbiomed.2007.06.014. [DOI] [PubMed] [Google Scholar]
  • 99.Maret W., Sandstead H.H. Zinc requirements and the risks and benefits of zinc supplementation. J. Trace Elem. Med. Biol. 2006;20:3–18. doi: 10.1016/j.jtemb.2006.01.006. [DOI] [PubMed] [Google Scholar]
  • 100.Hashimoto A., Kambe T. Mg, Zn and Cu transport proteins: a brief overview from physiological and molecular perspectives. J. Nutr. Sci. Vitaminol. 2015;61(Suppl):S116–S118. doi: 10.3177/jnsv.61.S116. [DOI] [PubMed] [Google Scholar]
  • 101.Andreini C., Banci L., Bertini I., Rosato A. Counting the zinc-proteins Encoded in the human genome. J. Proteome Res. 2006;5:196–201. doi: 10.1021/pr050361j. [DOI] [PubMed] [Google Scholar]
  • 102.Maares M., Haase H. A guide to human zinc absorption: general overview and recent advances of in vitro intestinal models. Nutrients. 2020;12 doi: 10.3390/nu12030762. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 103.Foote J.W., Delves H.T. Albumin bound and alpha 2-macroglobulin bound zinc concentrations in the sera of healthy adults. J. Clin. Pathol. 1984;37:1050–1054. doi: 10.1136/jcp.37.9.1050. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 104.Lee H.H., Prasad A.S., Brewer G.J., Owyang C. Zinc absorption in human small intestine. Am. J. Physiol. 1989;256 doi: 10.1152/ajpgi.1989.256.1.G87. G87-91. [DOI] [PubMed] [Google Scholar]
  • 105.Rink L., Haase H. Zinc homeostasis and immunity. Trends Immunol. 2007;28:1–4. doi: 10.1016/j.it.2006.11.005. [DOI] [PubMed] [Google Scholar]
  • 106.Lichten L.A., Cousins R.J. Mammalian zinc transporters: nutritional and physiologic regulation. Annu. Rev. Nutr. 2009;29:153–176. doi: 10.1146/annurev-nutr-033009-083312. [DOI] [PubMed] [Google Scholar]
  • 107.Kambe T., Tsuji T., Hashimoto A., Itsumura N. The physiological, biochemical, and molecular roles of zinc transporters in zinc homeostasis and metabolism. Physiol. Rev. 2015;95:749–784. doi: 10.1152/physrev.00035.2014. [DOI] [PubMed] [Google Scholar]
  • 108.Wellenreuther G., Cianci M., Tucoulou R., Meyer-Klaucke W., Haase H. The ligand environment of zinc stored in vesicles. Biochem. Biophys. Res. Commun. 2009;380:198–203. doi: 10.1016/j.bbrc.2009.01.074. [DOI] [PubMed] [Google Scholar]
  • 109.Thiers R.E., Vallee B.L. Distribution of metals in subcellular fractions of rat liver. J. Biol. Chem. 1957;226:911–920. [PubMed] [Google Scholar]
  • 110.Vallee B.L., Falchuk K.H. The biochemical basis of zinc physiology. Physiol. Rev. 1993;73:79–118. doi: 10.1152/physrev.1993.73.1.79. [DOI] [PubMed] [Google Scholar]
  • 111.Hanas J.S., Hazuda D.J., Bogenhagen D.F., Wu F.Y., Wu C.W. Xenopus transcription factor A requires zinc for binding to the 5 S RNA gene. J. Biol. Chem. 1983;258:14120–14125. [PubMed] [Google Scholar]
  • 112.Cassandri M. Zinc-finger proteins in health and disease. Cell Death Discovery. 2017;3 doi: 10.1038/cddiscovery.2017.71. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 113.Tupler R., Perini G., Green M.R. Expressing the human genome. Nature. 2001;409:832–833. doi: 10.1038/35057011. [DOI] [PubMed] [Google Scholar]
  • 114.Vallee B.L., Auld D.S. Functional zinc-binding motifs in enzymes and DNA-binding proteins. Faraday Discuss. 1992;93:47. doi: 10.1039/fd9929300047. [DOI] [PubMed] [Google Scholar]
  • 115.Auld D.S. Zinc coordination sphere in biochemical zinc sites. Biometals. 2001;14:271–313. doi: 10.1023/a:1012976615056. [DOI] [PubMed] [Google Scholar]
  • 116.Passerini A., Andreini C., Menchetti S., Rosato A., Frasconi P. Predicting zinc binding at the proteome level. BMC Bioinf. 2007;8 doi: 10.1186/1471-2105-8-39. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 117.Alker, Schwerdtle, Schomburg, Haase A zinpyr-1-based fluorimetric microassay for free zinc in human serum. Int. J. Mol. Sci. 2019;20:4006. doi: 10.3390/ijms20164006. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 118.Kochańczyk T., Drozd A., Krężel A. Relationship between the architecture of zinc coordination and zinc binding affinity in proteins – insights into zinc regulation. Metall. 2015;7:244–257. doi: 10.1039/c4mt00094c. [DOI] [PubMed] [Google Scholar]
  • 119.Bozym R.A. Free zinc ions outside a narrow concentration range are toxic to a variety of cellsin vitro. Exp. Biol. Med. 2010;235:741–750. doi: 10.1258/ebm.2010.009258. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 120.Maret W. Metals on the move: zinc ions in cellular regulation and in the coordination dynamics of zinc proteins. Biometals. 2011;24:411–418. doi: 10.1007/s10534-010-9406-1. [DOI] [PubMed] [Google Scholar]
  • 121.Wessels I., Maywald M., Rink L. Zinc as a gatekeeper of immune function. Nutrients. 2017;9 doi: 10.3390/nu9121286. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 122.Maywald M., Wessels I., Rink L. Zinc signals and immunity. Int. J. Mol. Sci. 2017;18:2222. doi: 10.3390/ijms18102222. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 123.Haase H., Hebel S., Engelhardt G., Rink L. Flow cytometric measurement of labile zinc in peripheral blood mononuclear cells. Anal. Biochem. 2006;352:222–230. doi: 10.1016/j.ab.2006.02.009. [DOI] [PubMed] [Google Scholar]
  • 124.Haase H. Zinc signals are essential for lipopolysaccharide-induced signal transduction in monocytes. J. Immunol. 2008;181:6491–6502. doi: 10.4049/jimmunol.181.9.6491. [DOI] [PubMed] [Google Scholar]
  • 125.Brieger A., Rink L., Haase H. Differential regulation of TLR-dependent MyD88 and TRIF signaling pathways by free zinc ions. J. Immunol. 2013;191:1808–1817. doi: 10.4049/jimmunol.1301261. [DOI] [PubMed] [Google Scholar]
  • 126.Maret W. Zinc in cellular regulation: the nature and significance of “zinc signals”. Int. J. Mol. Sci. 2017;18:2285. doi: 10.3390/ijms18112285. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 127.Maret W. The function of zinc metallothionein: a link between cellular zinc and redox state. J. Nutr. 2000;130:1455S–1458S. doi: 10.1093/jn/130.5.1455s. [DOI] [PubMed] [Google Scholar]
  • 128.Korichneva I., Hoyos B., Chua R., Levi E., Hammerling U. Zinc release from protein kinase C as the common event during activation by lipid second messenger or reactive oxygen. J. Biol. Chem. 2002;277:44327–44331. doi: 10.1074/jbc.m205634200. [DOI] [PubMed] [Google Scholar]
  • 129.Turan B., Fliss H., Desilets M. Oxidants increase intracellular free Zn2+ concentration in rabbit ventricular myocytes. Am. J. Physiol. 1997;272:H2095–H2106. doi: 10.1152/ajpheart.1997.272.5.H2095. [DOI] [PubMed] [Google Scholar]
  • 130.Margoshes M., Vallee B.L.A. Cadmium protein from equine kidney cortex. J. Am. Chem. Soc. 1957;79:4813–4814. doi: 10.1021/ja01574a064. [DOI] [Google Scholar]
  • 131.Kagi J.H., Valee B.L. Metallothionein: a cadmium- and zinc-containing protein from equine renal cortex. J. Biol. Chem. 1960;235:3460–3465. [PubMed] [Google Scholar]
  • 132.Kimura T., Kambe T. The functions of metallothionein and ZIP and ZnT transporters: an overview and perspective. Int. J. Mol. Sci. 2016;17:336. doi: 10.3390/ijms17030336. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 133.Thirumoorthy N. A review of metallothionein isoforms and their role in pathophysiology. World J. Surg. Oncol. 2011;9:54. doi: 10.1186/1477-7819-9-54. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 134.Bell S.G., Vallee B.L. The metallothionein/thionein system: an oxidoreductive metabolic zinc link. Chembiochem. 2009;10:55–62. doi: 10.1002/cbic.200800511. [DOI] [PubMed] [Google Scholar]
  • 135.Go Y.-M., Chandler J.D., Jones D.P. The cysteine proteome. Free Radic. Biol. Med. 2015;84:227–245. doi: 10.1016/j.freeradbiomed.2015.03.022. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 136.Bulaj G., Kortemme T., Goldenberg D.P. Ionization-reactivity relationships for cysteine thiols in polypeptides. Biochemistry. 1998;37:8965–8972. doi: 10.1021/bi973101r. [DOI] [PubMed] [Google Scholar]
  • 137.Paulsen C.E., Carroll K.S. Cysteine-mediated redox signaling: chemistry, biology, and tools for discovery. Chem. Rev. 2013;113:4633–4679. doi: 10.1021/cr300163e. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 138.García-Santamarina S., Boronat S., Hidalgo E. Reversible cysteine oxidation in hydrogen peroxide sensing and signal transduction. Biochemistry. 2014;53:2560–2580. doi: 10.1021/bi401700f. [DOI] [PubMed] [Google Scholar]
  • 139.Lutolf M.P., Tirelli N., Cerritelli S., Cavalli L., Hubbell J.A. Systematic modulation of michael-type reactivity of thiols through the use of charged amino acids. Bioconjugate Chem. 2001;12:1051–1056. doi: 10.1021/bc015519e. [DOI] [PubMed] [Google Scholar]
  • 140.Roos G., Foloppe N., Messens J. Understanding the pK(a) of redox cysteines: the key role of hydrogen bonding. Antioxidants Redox Signal. 2013;18:94–127. doi: 10.1089/ars.2012.4521. [DOI] [PubMed] [Google Scholar]
  • 141.Winterbourn C.C., Hampton M.B. Thiol chemistry and specificity in redox signaling. Free Radic. Biol. Med. 2008;45:549–561. doi: 10.1016/j.freeradbiomed.2008.05.004. [DOI] [PubMed] [Google Scholar]
  • 142.Jacob C., Giles G.I., Giles N.M., Sies H. Sulfur and selenium: the role of oxidation state in protein structure and function. Angew. Chem. Int. Ed. 2003;42:4742–4758. doi: 10.1002/anie.200300573. [DOI] [PubMed] [Google Scholar]
  • 143.Winterbourn C.C., Metodiewa D. Reactivity of biologically important thiol compounds with superoxide and hydrogen peroxide. Free Radic. Biol. Med. 1999;27:322–328. doi: 10.1016/s0891-5849(99)00051-9. [DOI] [PubMed] [Google Scholar]
  • 144.Woo H.A. Reduction of cysteine sulfinic acid by sulfiredoxin is specific to 2-cys peroxiredoxins. J. Biol. Chem. 2005;280:3125–3128. doi: 10.1074/jbc.c400496200. [DOI] [PubMed] [Google Scholar]
  • 145.Biteau B., Labarre J., Toledano M.B. ATP-dependent reduction of cysteine–sulphinic acid by S. cerevisiae sulphiredoxin. Nature. 2003;425:980–984. doi: 10.1038/nature02075. [DOI] [PubMed] [Google Scholar]
  • 146.Miller G.W., Jones D.P. The nature of nurture: refining the definition of the exposome. Toxicol. Sci. 2014;137:1–2. doi: 10.1093/toxsci/kft251. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 147.Sakulsak N. Metallothionein: an overview on its metal homeostatic regulation in mammals. Int. J. Morphol. 2012;30:1007–1012. [Google Scholar]
  • 148.Maret W. Redox biochemistry of mammalian metallothioneins. J. Biol. Inorg. Chem. 2011;16:1079–1086. doi: 10.1007/s00775-011-0800-0. [DOI] [PubMed] [Google Scholar]
  • 149.Cousins R.J., Liuzzi J.P., Lichten L.A. Mammalian zinc transport, trafficking, and signals. J. Biol. Chem. 2006;281:24085–24089. doi: 10.1074/jbc.r600011200. [DOI] [PubMed] [Google Scholar]
  • 150.KrȩŻel A., Maret W. Dual nanomolar and picomolar Zn(II) binding properties of metallothionein. J. Am. Chem. Soc. 2007;129:10911–10921. doi: 10.1021/ja071979s. [DOI] [PubMed] [Google Scholar]
  • 151.Haase H., Maret W. Partial oxidation and oxidative polymerization of metallothionein. Electrophoresis. 2008;29:4169–4176. doi: 10.1002/elps.200700922. [DOI] [PubMed] [Google Scholar]
  • 152.Krężel A., Maret W. The functions of metamorphic metallothioneins in zinc and copper metabolism. Int. J. Mol. Sci. 2017;18:1237. doi: 10.3390/ijms18061237. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 153.Beyersmann D., Hechtenberg S. Cadmium, gene regulation, and cellular signalling in mammalian cells. Toxicol. Appl. Pharmacol. 1997;144:247–261. doi: 10.1006/taap.1997.8125. [DOI] [PubMed] [Google Scholar]
  • 154.Andrews G.K. Regulation of metallothionein gene expression by oxidative stress and metal ions. Biochem. Pharmacol. 2000;59:95–104. doi: 10.1016/s0006-2952(99)00301-9. [DOI] [PubMed] [Google Scholar]
  • 155.Colvin R.A., Holmes W.R., Fontaine C.P., Maret W. Cytosolic zinc buffering and muffling: their role in intracellular zinc homeostasis. Metall. 2010;2:306. doi: 10.1039/b926662c. [DOI] [PubMed] [Google Scholar]
  • 156.Haase H., Maret W. A differential assay for the reduced and oxidized states of metallothionein and thionein. Anal. Biochem. 2004;333:19–26. doi: 10.1016/j.ab.2004.04.039. [DOI] [PubMed] [Google Scholar]
  • 157.Zangger K., Shen G., Öz G., Otvos J.D., Armitage I.M. Oxidative dimerization in metallothionein is a result of intermolecular disulphide bonds between cysteines in the α-domain. Biochem. J. 2001;359:353. doi: 10.1042/0264-6021:3590353. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 158.Chen Y., Maret W. Catalytic selenols couple the redox cycles of metallothionein and glutathione. Eur. J. Biochem. 2001;268:3346–3353. doi: 10.1046/j.1432-1327.2001.02250.x. [DOI] [PubMed] [Google Scholar]
  • 159.Krężel A., Maret W. Thionein/metallothionein control Zn(II) availability and the activity of enzymes. J. Biol. Inorg. Chem. 2008;13:401–409. doi: 10.1007/s00775-007-0330-y. [DOI] [PubMed] [Google Scholar]
  • 160.Yang Y., Maret W., Vallee B.L. Differential fluorescence labeling of cysteinyl clusters uncovers high tissue levels of thionein. Proc. Natl. Acad. Sci. U.S.A. 2001;98:5556–5559. doi: 10.1073/pnas.101123298. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 161.Cherian M.G., Apostolova M.D. Nuclear localization of metallothionein during cell proliferation and differentiation. Cell. Mol. Biol. 2000;46:347–356. [PubMed] [Google Scholar]
  • 162.Li Y., Maret W. Human metallothionein metallomics. J. Anal. Atomic Spectrom. 2008;23:1055. doi: 10.1039/b802220h. [DOI] [Google Scholar]
  • 163.Dalton T., Palmiter R.D., Andrews G.K. Transcriptional induction of the mouse metallothionein-I gene in hydrogen peroxide-treated Hepa cells involves a composite major late transcription factor/antioxidant response element and metal response promoter elements. Nucleic Acids Res. 1994;22:5016–5023. doi: 10.1093/nar/22.23.5016. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 164.Kelly E.J., Sandgren E.P., Brinster R.L., Palmiter R.D. A pair of adjacent glucocorticoid response elements regulate expression of two mouse metallothionein genes. Proc. Natl. Acad. Sci. U.S.A. 1997;94:10045–10050. doi: 10.1073/pnas.94.19.10045. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 165.Radtke F. Cloned transcription factor MTF-1 activates the mouse metallothionein I promoter. EMBO J. 1993;12:1355–1362. doi: 10.1002/j.1460-2075.1993.tb05780.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 166.Andrews G.K. Cellular zinc sensors: MTF-1 regulation of gene expression. Biometals. 2001;14:223–237. doi: 10.1023/a:1012932712483. [DOI] [PubMed] [Google Scholar]
  • 167.Zhang B. Activity of metal-responsive transcription factor 1 by toxic heavy metals and H2O2 in vitro is modulated by metallothionein. Mol. Cell Biol. 2003;23:8471–8485. doi: 10.1128/MCB.23.23.8471-8485.2003. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 168.Foster D.B., Van Eyk J.E., Marbán E., O’Rourke B. Redox signaling and protein phosphorylation in mitochondria: progress and prospects. J. Bioenerg. Biomembr. 2009;41:159–168. doi: 10.1007/s10863-009-9217-7. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 169.Pillay C.S., Eagling B.D., Driscoll S.R.E., Rohwer J.M. Quantitative measures for redox signaling. Free Radic. Biol. Med. 2016;96:290–303. doi: 10.1016/j.freeradbiomed.2016.04.199. [DOI] [PubMed] [Google Scholar]
  • 170.Dröge W. Free radicals in the physiological control of cell function. Physiol. Rev. 2002;82:47–95. doi: 10.1152/physrev.00018.2001. [DOI] [PubMed] [Google Scholar]
  • 171.Forman H.J., Ursini F., Maiorino M. An overview of mechanisms of redox signaling. J. Mol. Cell. Cardiol. 2014;73:2–9. doi: 10.1016/j.yjmcc.2014.01.018. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 172.Sies H. Hydrogen peroxide as a central redox signaling molecule in physiological oxidative stress: oxidative eustress. Redox Biology. 2017;11:613–619. doi: 10.1016/j.redox.2016.12.035. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 173.Marinho H.S., Real C., Cyrne L., Soares H., Antunes F. Hydrogen peroxide sensing, signaling and regulation of transcription factors. Redox Biology. 2014;2:535–562. doi: 10.1016/j.redox.2014.02.006. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 174.Maret W. Zinc and sulfur: a critical biological partnership. Biochemistry. 2004;43:3301–3309. doi: 10.1021/bi036340p. [DOI] [PubMed] [Google Scholar]
  • 175.Maret W. Zinc coordination environments in proteins as redox sensors and signal transducers. Antioxidants Redox Signal. 2006;8:1419–1441. doi: 10.1089/ars.2006.8.1419. [DOI] [PubMed] [Google Scholar]
  • 176.Maret W. Cellular zinc and redox states converge in the metallothionein/thionein pair. J. Nutr. 2003;133:1460s–1462s. doi: 10.1093/jn/133.5.1460S. [DOI] [PubMed] [Google Scholar]
  • 177.Kansanen E., Kuosmanen S.M., Leinonen H., Levonen A.-L. The Keap1-Nrf2 pathway: mechanisms of activation and dysregulation in cancer. Redox Biology. 2013;1:45–49. doi: 10.1016/j.redox.2012.10.001. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 178.Itoh K. An nrf2/small maf heterodimer mediates the induction of phase II detoxifying enzyme genes through antioxidant response elements. Biochem. Biophys. Res. Commun. 1997;236:313–322. doi: 10.1006/bbrc.1997.6943. [DOI] [PubMed] [Google Scholar]
  • 179.Taguchi K., Motohashi H., Yamamoto M. Molecular mechanisms of the Keap1-Nrf2 pathway in stress response and cancer evolution. Gene Cell. 2011;16:123–140. doi: 10.1111/j.1365-2443.2010.01473.x. [DOI] [PubMed] [Google Scholar]
  • 180.Wild A.C., Moinova H.R., Mulcahy R.T. Regulation of -glutamylcysteine synthetase subunit gene expression by the transcription factor Nrf2. J. Biol. Chem. 1999;274:33627–33636. doi: 10.1074/jbc.274.47.33627. [DOI] [PubMed] [Google Scholar]
  • 181.McMahon M., Swift S.R., Hayes J.D. Zinc-binding triggers a conformational-switch in the cullin-3 substrate adaptor protein KEAP1 that controls transcription factor NRF2. Toxicol. Appl. Pharmacol. 2018;360:45–57. doi: 10.1016/j.taap.2018.09.033. [DOI] [PubMed] [Google Scholar]
  • 182.Cortese M.M., Suschek C.V., Wetzel W., Kroncke K.D., Kolb-Bachofen V. Zinc protects endothelial cells from hydrogen peroxide via Nrf2-dependent stimulation of glutathione biosynthesis. Free Radic. Biol. Med. 2008;44:2002–2012. doi: 10.1016/j.freeradbiomed.2008.02.013. [DOI] [PubMed] [Google Scholar]
  • 183.Cortese-Krott M.M., Suschek C.V., Wetzel W., Kroncke K.D., Kolb-Bachofen V. Nitric oxide-mediated protection of endothelial cells from hydrogen peroxide is mediated by intracellular zinc and glutathione. Am. J. Physiol. Cell Physiol. 2009;296:C811–C820. doi: 10.1152/ajpcell.00643.2008. [DOI] [PubMed] [Google Scholar]
  • 184.Li B. Zinc is essential for the transcription function of Nrf2 in human renal tubule cells in vitro and mouse kidney in vivo under the diabetic condition. J. Cell Mol. Med. 2014;18:895–906. doi: 10.1111/jcmm.12239. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 185.Yang C., Arrizabalaga G. The serine/threonine phosphatases of apicomplexan parasites. Mol. Microbiol. 2017;106:1–21. doi: 10.1111/mmi.13715. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 186.Ardito F., Giuliani M., Perrone D., Troiano G., Lo Muzio L. The crucial role of protein phosphorylation in cell signaling and its use as targeted therapy (Review) Int. J. Mol. Med. 2017;40:271–280. doi: 10.3892/ijmm.2017.3036. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 187.Tonks N.K. Protein tyrosine phosphatases: from genes, to function, to disease. Nat. Rev. Mol. Cell Biol. 2006;7:833–846. doi: 10.1038/nrm2039. [DOI] [PubMed] [Google Scholar]
  • 188.Bellomo E., Birla Singh K., Massarotti A., Hogstrand C., Maret W. The metal face of protein tyrosine phosphatase 1B. Coord. Chem. Rev. 2016;327–328:70–83. doi: 10.1016/j.ccr.2016.07.002. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 189.Brautigan D.L., Bornstein P., Gallis B. Phosphotyrosyl-protein phosphatase. Specific inhibition by Zn. J. Biol. Chem. 1981;256:6519–6522. [PubMed] [Google Scholar]
  • 190.Maret W., Jacob C., Vallee B.L., Fischer E.H. Inhibitory sites in enzymes: zinc removal and reactivation by thionein. Proc. Natl. Acad. Sci. U.S.A. 1999;96:1936–1940. doi: 10.1073/pnas.96.5.1936. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 191.Kenner K.A., Anyanwu E., Olefsky J.M., Kusari J. Protein-tyrosine phosphatase 1B is a negative regulator of insulin- and insulin-like growth factor-I-stimulated signaling. J. Biol. Chem. 1996;271:19810–19816. doi: 10.1074/jbc.271.33.19810. [DOI] [PubMed] [Google Scholar]
  • 192.Elchebly M. Increased insulin sensitivity and obesity resistance in mice lacking the protein tyrosine phosphatase-1B gene. Science. 1999;283:1544–1548. doi: 10.1126/science.283.5407.1544. [DOI] [PubMed] [Google Scholar]
  • 193.Haase H., Maret W. Intracellular zinc fluctuations modulate protein tyrosine phosphatase activity in insulin/insulin-like growth factor-1 signaling. Exp. Cell Res. 2003;291:289–298. doi: 10.1016/S0014-4827(03)00406-3. [DOI] [PubMed] [Google Scholar]
  • 194.Wilson M., Hogstrand C., Maret W. Picomolar concentrations of free zinc(II) ions regulate receptor protein-tyrosine phosphatase activity. J. Biol. Chem. 2012;287:9322–9326. doi: 10.1074/jbc.c111.320796. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 195.Plum L.M. PTEN-inhibition by zinc ions augments interleukin-2-mediated Akt phosphorylation. Metall. 2014;6:1277. doi: 10.1039/c3mt00197k. [DOI] [PubMed] [Google Scholar]
  • 196.Bellomo E., Massarotti A., Hogstrand C., Maret W. Zinc ions modulate protein tyrosine phosphatase 1B activity. Metall. 2014;6:1229–1239. doi: 10.1039/c4mt00086b. [DOI] [PubMed] [Google Scholar]
  • 197.Haase H., Maret W. Protein tyrosine phosphatases as targets of the combined insulinomimetic effects of zinc and oxidants. Biometals. 2005;18:333–338. doi: 10.1007/s10534-005-3707-9. [DOI] [PubMed] [Google Scholar]
  • 198.Dadke S., Kusari A., Kusari J. Phosphorylation and activation of protein tyrosine phosphatase (PTP) 1B by insulin receptor. Mol. Cell. Biochem. 2001;221:147–154. doi: 10.1023/a:1010909031310. [DOI] [PubMed] [Google Scholar]
  • 199.Peters G.H., Frimurer T.M., Olsen O.H. Electrostatic Evaluation of the signature motif (H/V)CX 5 R(S/T) in Protein−Tyrosine phosphatases †. Biochemistry. 1998;37:5383–5393. doi: 10.1021/bi971187i. [DOI] [PubMed] [Google Scholar]
  • 200.Denu J.M., Tanner K.G. Specific and reversible inactivation of protein tyrosine phosphatases by hydrogen peroxide: evidence for a sulfenic acid intermediate and implications for redox regulation †. Biochemistry. 1998;37:5633–5642. doi: 10.1021/bi973035t. [DOI] [PubMed] [Google Scholar]
  • 201.Kwon J. Reversible oxidation and inactivation of the tumor suppressor PTEN in cells stimulated with peptide growth factors. Proc. Natl. Acad. Sci. Unit. States Am. 2004;101:16419–16424. doi: 10.1073/pnas.0407396101. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 202.Östman A., Frijhoff J., Sandin Å., Böhmer F.-D. Regulation of protein tyrosine phosphatases by reversible oxidation. J. Biochem. 2011;150:345–356. doi: 10.1093/jb/mvr104. [DOI] [PubMed] [Google Scholar]
  • 203.Salmeen A. Redox regulation of protein tyrosine phosphatase 1B involves a sulphenyl-amide intermediate. Nature. 2003;423:769–773. doi: 10.1038/nature01680. [DOI] [PubMed] [Google Scholar]
  • 204.Cho S.-H. Redox regulation of PTEN and protein tyrosine phosphatases in H2O2- mediated cell signaling. FEBS Letters. 2004;560:7–13. doi: 10.1016/s0014-5793(04)00112-7. [DOI] [PubMed] [Google Scholar]
  • 205.Verrastro I., Tveen-Jensen K., Spickett C.M., Pitt A.R. The effect of HOCl-induced modifications on phosphatase and tensin homologue (PTEN) structure and function. Free Radic. Res. 2018:1–16. doi: 10.1080/10715762.2018.1424333. [DOI] [PubMed] [Google Scholar]
  • 206.Kaltenberg J. Zinc signals promote IL-2-dependent proliferation of T cells. Eur. J. Immunol. 2010;40:1496–1503. doi: 10.1002/eji.200939574. [DOI] [PubMed] [Google Scholar]
  • 207.Levinthal D.J., Defranco D.B. Reversible oxidation of ERK-directed protein phosphatases drives oxidative toxicity in neurons. J. Biol. Chem. 2005;280:5875–5883. doi: 10.1074/jbc.m410771200. [DOI] [PubMed] [Google Scholar]
  • 208.Santos C.X. Targeted redox inhibition of protein phosphatase 1 by Nox4 regulates eIF2 -mediated stress signaling. EMBO J. 2016;35:319–334. doi: 10.15252/embj.201592394. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 209.Xiong Y. Zinc binds to and directly inhibits protein phosphatase 2A in vitro. Neuroscience Bulletin. 2015;31:331–337. doi: 10.1007/s12264-014-1519-z. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 210.Zhuo S., Dixon J.E. Effects of sulfhydryl regents on the activity of lambda Ser/Thr phosphoprotein phosphatase and inhibition of the enzyme by zinc ion. Protein Eng. Des. Sel. 1997;10:1445–1452. doi: 10.1093/protein/10.12.1445. [DOI] [PubMed] [Google Scholar]
  • 211.Hönscheid A., Dubben S., Rink L., Haase H. Zinc differentially regulates mitogen-activated protein kinases in human T cells. J. Nutr. Biochem. 2012;23:18–26. doi: 10.1016/j.jnutbio.2010.10.007. [DOI] [PubMed] [Google Scholar]
  • 212.Son Y., Kim S., Chung H.T., Pae H.O. Reactive oxygen species in the activation of MAP kinases. Methods Enzymol. 2013;528:27–48. doi: 10.1016/b978-0-12-405881-1.00002-1. [DOI] [PubMed] [Google Scholar]
  • 213.Saitoh M. Mammalian thioredoxin is a direct inhibitor of apoptosis signal-regulating kinase (ASK) EMBO J. 1998;17:2596–2606. doi: 10.1093/emboj/17.9.2596. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 214.Fujisawa T., Takeda K., Ichijo H. ASK family proteins in stress response and disease. Mol. Biotechnol. 2007;37:13–18. doi: 10.1007/s12033-007-0053-x. [DOI] [PubMed] [Google Scholar]
  • 215.Collet J.F., D'Souza J.C., Jakob U., Bardwell J.C.A. Thioredoxin 2, an oxidative stress-induced protein, contains a high affinity zinc binding site. J. Biol. Chem. 2003;278:45325–45332. doi: 10.1074/jbc.m307818200. [DOI] [PubMed] [Google Scholar]
  • 216.Verbon E.H., Post J.A., Boonstra J. The influence of reactive oxygen species on cell cycle progression in mammalian cells. Gene. 2012;511:1–6. doi: 10.1016/j.gene.2012.08.038. [DOI] [PubMed] [Google Scholar]
  • 217.Oteiza P.I. Zinc and the modulation of redox homeostasis. Free Radic. Biol. Med. 2012;53:1748–1759. doi: 10.1016/j.freeradbiomed.2012.08.568. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 218.von Bülow V. Zinc-dependent suppression of TNF-alpha production is mediated by protein kinase A-induced inhibition of Raf-1, I kappa B kinase beta, and NF-kappa B. J. Immunol. 2007;179:4180–4186. doi: 10.4049/jimmunol.179.6.4180. [DOI] [PubMed] [Google Scholar]
  • 219.Nuttall J.R., Oteiza P.I. Zinc and the ERK kinases in the developing brain. Neurotox. Res. 2012;21:128–141. doi: 10.1007/s12640-011-9291-6. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 220.Haase H., Rink L. Functional significance of zinc-related signaling pathways in immune cells. Annu. Rev. Nutr. 2009;29:133–152. doi: 10.1146/annurev-nutr-080508-141119. [DOI] [PubMed] [Google Scholar]
  • 221.Steinberg S.F. Mechanisms for redox-regulation of protein kinase C. Front. Pharmacol. 2015;6 doi: 10.3389/fphar.2015.00128. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 222.Knapp L.T., Klann E. Superoxide-induced stimulation of protein kinase C via thiol modification and modulation of zinc content. J. Biol. Chem. 2000;275:24136–24145. doi: 10.1074/jbc.m002043200. [DOI] [PubMed] [Google Scholar]
  • 223.Slepchenko K.G., Holub J.M., Li Y.V. Intracellular zinc increase affects phosphorylation state and subcellular localization of protein kinase C delta (δ) Cell. Signal. 2018;44:148–157. doi: 10.1016/j.cellsig.2018.01.018. [DOI] [PubMed] [Google Scholar]
  • 224.Van Opdenbosch N., Lamkanfi M. Caspases in cell death, inflammation, and disease. Immunity. 2019;50:1352–1364. doi: 10.1016/j.immuni.2019.05.020. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 225.Eron S.J., Macpherson D.J., Dagbay K.B., Hardy J.A. Multiple mechanisms of zinc-mediated inhibition for the apoptotic caspases-3, -6, -7, and -8. ACS Chem. Biol. 2018 doi: 10.1021/acschembio.8b00064. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 226.Daniel A.G., Peterson E.J., Farrell N.P. The bioinorganic chemistry of apoptosis: potential inhibitory zinc binding sites in caspase-3. Angew. Chem. Int. Ed. 2014;53:4098–4101. doi: 10.1002/anie.201311114. [DOI] [PubMed] [Google Scholar]
  • 227.Velazquez-Delgado E.M., Hardy J.A. Zinc-mediated allosteric inhibition of caspase-6. J. Biol. Chem. 2012;287:36000–36011. doi: 10.1074/jbc.m112.397752. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 228.Stennicke H.R., Salvesen G.S. Biochemical characteristics of caspases-3, -6, -7, and -8. J. Biol. Chem. 1997;272:25719–25723. doi: 10.1074/jbc.272.41.25719. [DOI] [PubMed] [Google Scholar]
  • 229.Huber K.L., Hardy J.A. Mechanism of zinc-mediated inhibition of caspase-9. Protein Sci. 2012;21:1056–1065. doi: 10.1002/pro.2090. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 230.Huang Z., Pinto J.T., Deng H., Richie J.P. Inhibition of caspase-3 activity and activation by protein glutathionylation. Biochem. Pharmacol. 2008;75:2234–2244. doi: 10.1016/j.bcp.2008.02.026. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 231.Kim J.-E., Tannenbaum S.R. S-nitrosation regulates the activation of Endogenous procaspase-9 in HT-29 human colon carcinoma cells. J. Biol. Chem. 2004;279:9758–9764. doi: 10.1074/jbc.m312722200. [DOI] [PubMed] [Google Scholar]
  • 232.Braunstein I. Opposing effects of polysulfides and thioredoxin on apoptosis through caspase persulfidation. J. Biol. Chem. 2020;295:3590–3600. doi: 10.1074/jbc.RA119.012357. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 233.Kleinman W.A., Richie J.P., Jr. Determination of thiols and disulfides using high-performance liquid chromatography with electrochemical detection. J. Chromatogr. B Biomed. Sci. Appl. 1995;672:73–80. doi: 10.1016/0378-4347(94)00194-a. [DOI] [PubMed] [Google Scholar]
  • 234.Rössig L. Nitric oxide inhibits caspase-3 byS-nitrosationin vivo. J. Biol. Chem. 1999;274:6823–6826. doi: 10.1074/jbc.274.11.6823. [DOI] [PubMed] [Google Scholar]
  • 235.Lönnerdal B. Dietary factors influencing zinc absorption. J. Nutr. 2000;130:1378S–1383S. doi: 10.1093/jn/130.5.1378s. [DOI] [PubMed] [Google Scholar]
  • 236.Prasad A.S. Discovery of human zinc deficiency: its impact on human health and disease. Advances in Nutrition. 2013;4:176–190. doi: 10.3945/an.112.003210. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 237.Choi S., Liu X., Pan Z. Zinc deficiency and cellular oxidative stress: prognostic implications in cardiovascular diseases. Acta Pharmacol. Sin. 2018;39:1120–1132. doi: 10.1038/aps.2018.25. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 238.Haase H., Mocchegiani E., Rink L. Correlation between zinc status and immune function in the elderly. Biogerontology. 2006;7:421–428. doi: 10.1007/s10522-006-9057-3. [DOI] [PubMed] [Google Scholar]
  • 239.Haase H., Rink L. The immune system and the impact of zinc during aging. Immun. Ageing. 2009;6:9. doi: 10.1186/1742-4933-6-9. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 240.Prasad A.S. Zinc supplementation decreases incidence of infections in the elderly: effect of zinc on generation of cytokines and oxidative stress. Am. J. Clin. Nutr. 2007;85:837–844. doi: 10.1093/ajcn/85.3.837. [DOI] [PubMed] [Google Scholar]
  • 241.Lee S.R. Critical role of zinc as either an antioxidant or a prooxidant in cellular systems. Oxidative.Med. Cell.Longevity. 2018;2018:1–11. doi: 10.1155/2018/9156285. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 242.Sheline C.T., Behrens M.M., Choi D.W. Zinc-induced cortical neuronal death: contribution of energy failure attributable to loss of NAD(+) and inhibition of glycolysis. J. Neurosci. 2000;20:3139–3146. doi: 10.1523/JNEUROSCI.20-09-03139.2000. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 243.Ikeda T., Kimura K., Morioka S., Tamaki N. Inhibitory effects of Zn2+ on muscle glycolysis and their reversal by histidine. J. Nutr. Sci. Vitaminol. 1980;26:357–366. doi: 10.3177/jnsv.26.357. [DOI] [PubMed] [Google Scholar]
  • 244.Gazaryan I.G. Zinc is a potent inhibitor of thiol oxidoreductase activity and stimulates reactive oxygen species production by lipoamide dehydrogenase. J. Biol. Chem. 2002;277:10064–10072. doi: 10.1074/jbc.m108264200. [DOI] [PubMed] [Google Scholar]
  • 245.Oteiza P. Zinc deficiency induces oxidative stress and AP-1 activation in 3T3 cells. Free Radic. Biol. Med. 2000;28:1091–1099. doi: 10.1016/s0891-5849(00)00200-8. [DOI] [PubMed] [Google Scholar]
  • 246.Reeves P.G., Rossow K.L., Bobilya D.J. Zinc-induced metallothionein and copper metabolism in intestinal mucosa, liver, and kidney of rats. Nutr. Res. 1993;13:1419–1431. doi: 10.1016/s0271-5317(05)80791-2. [DOI] [Google Scholar]
  • 247.Supasai S., Aimo L., Adamo A.M., Mackenzie G.G., Oteiza P.I. Zinc deficiency affects the STAT1/3 signaling pathways in part through redox-mediated mechanisms. Redox Biology. 2017;11:469–481. doi: 10.1016/j.redox.2016.12.027. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 248.Zago M.P., Mackenzie G.G., Adamo A.M., Keen C.L., Oteiza P.I. Differential modulation of MAP kinases by zinc deficiency in IMR-32 cells: role of H2O2. Antioxidants Redox Signal. 2005;7:1773–1782. doi: 10.1089/ars.2005.7.1773. [DOI] [PubMed] [Google Scholar]
  • 249.Oteiza P.I., Clegg M.S., Keen C.L. Short-term zinc deficiency affects nuclear factor-kappab nuclear binding activity in rat testes. J. Nutr. 2001;131:21–26. doi: 10.1093/jn/131.1.21. [DOI] [PubMed] [Google Scholar]
  • 250.Omata Y., Salvador G.A., Supasai S., Keenan A.H., Oteiza P.I. Decreased zinc availability affects glutathione metabolism in neuronal cells and in the developing brain. Toxicol. Sci. 2013;133:90–100. doi: 10.1093/toxsci/kft022. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Redox Biology are provided here courtesy of Elsevier

RESOURCES